Busca un médico

Eoin P. Flanagan, M.B., B.Ch.

  1. Neurologist
Solicite una Consulta

Publicaciones

  1. Zhao-Fleming H, Rezk M, Shah S, Gupta P, Zekeridou A, Flanagan EP, Pittock SJ, McKeon A, Dubey D. Comprehensive Analysis of Paraneoplastic Neurologic Syndrome and PNS-CARE Diagnostic Criteria in Clinical Practice. Neurol Neuroimmunol Neuroinflamm. 2024 Dec; 11 (6):e200316 Epub 2024 Sept 25
    View PubMed
  2. Nathoo N, Neyal N, Atkinson EJ, Weinshenker BG, Tillema JM, Keegan BM, Pittock SJ, Tobin WO, Flanagan EP, Gavrilova R, Toledano M, Young N, Truitt K, Okuda DT, Zeydan B, Kantarci OH. Multiple sclerosis in Somali Americans: Nature or nurture? Mult Scler Relat Disord. 2024 Oct; 90:105842 Epub 2024 Aug 29
    View PubMed
  3. Tisavipat N, Rattanathamsakul N, Salman AR, Cacciaguerra L, Pittock SJ, Flanagan EP, Chen JJ. Intracranial Pressure Elevation and MOGAD. JAMA Neurol. 2024 Sep 16 Epub 2024 Sept 16
    View PubMed
  4. Mangioris G, Orozco E, Dubey D, Flanagan EP, Pittock SJ, Zekeridou A, McKeon A. Long-term outcomes in antibody-negative autoimmune encephalitis: a retrospective study. J Neurol. 2024 Sep 15 Epub 2024 Sept 15
    View PubMed
  5. Tajfirouz D, Madhavan A, Pacheco Marrero JM, Krecke KN, Fautsch KJ, Flanagan EP, Pittock SJ, Shah S, Bhatti MT, Chen JJ. Frequency of Asymptomatic Optic Nerve Enhancement in 203 Patients With MOG Antibody-Associated Disease. Neurol Neuroimmunol Neuroinflamm. 2024 Sep; 11 (5):e200277 Epub 2024 June 26
    View PubMed
  6. Handzic A, Xie JS, Tisavipat N, O'Cearbhaill RM, Tajfirouz DA, Chodnicki KD, Flanagan EP, Chen JJ, Micieli J, Margolin E. Radiologic Predictors of Visual Outcome in Myelin Oligodendrocyte Glycoprotein-Related Optic Neuritis. Ophthalmology. 2024 Aug 14 [Epub ahead of print]
    View PubMed
  7. Klyscz P, Asseyer S, Alonso R, Bereuter C, Bialer O, Bick A, Carta S, Chen JJ, Cohen L, Cohen-Tayar Y, Carnero Contentti E, Dale RC, Flanagan EP, Gernert JA, Haas J, Havla J, Heesen C, Hellmann M, Levin N, Lopez P, Lotan I, Luis MB, Mariotto S, Mayer C, Vergara AJM, Ocampo C, Ochoa S, Oertel FC, Olszewska M, Uribe JLP, Sastre-Garriga J, Scocco D, Ramanathan S, Rattanathamsakul N, Shi FD, Shifa J, Simantov I, Siritho S, Tiosano A, Tisavipat N, Torres I, Dembinsky AV, Vidal-Jordana A, Wilf-Yarkoni A, Wu T, Zamir S, Zarco LA, Zimmermann HG, Petzold A, Paul F, Stiebel-Kalish H. Application of the international criteria for optic neuritis in the Acute Optic Neuritis Network. Ann Clin Transl Neurol. 2024 Aug 4 Epub 2024 Aug 04
    View PubMed
  8. Mangioris G, Pittock SJ, Yang B, Fryer JP, Harmsen WS, Dubey D, Flanagan EP, Lopez-Chiriboga SA, McKeon A, Mills JR, Vodopivec I, Tobin WO, Toledano M, Aksamit AJ, Zekeridou A. Cerebrospinal Fluid Cytokine and Chemokine Profiles in Central Nervous System Sarcoidosis: Diagnostic and Immunopathologic Insights. Ann Neurol. 2024 Jul 19 Epub 2024 July 19
    View PubMed
  9. Keegan BM, Messina SA, Hanson D, Holmes D, Camp J, Sechi E, Nayak S, Barakat B, Ahmad R, Mandrekar J, Harmsen WS, Kantarci O, Weinshenker BG, Flanagan EP. MR Imaging Features of Critical Spinal Demyelinating Lesions Associated with Progressive Motor Impairment. AJNR Am J Neuroradiol. 2024 Jul 8; 45 (7):943-950 Epub 2024 July 08
    View PubMed
  10. Virupakshaiah A, Schoeps VA, Race J, Waltz M, Sharayah S, Nasr Z, Moseley CE, Zamvil SS, Gaudioso C, Schuette A, Casper TC, Rose J, Flanagan EP, Rodriguez M, Tillema JM, Chitnis T, Gorman MP, Graves JS, Benson LA, Rensel M, Abrams A, Krupp L, Lotze TE, Aaen G, Wheeler Y, Schreiner T, Waldman A, Chong J, Mar S, Waubant E. Predictors of a relapsing course in myelin oligodendrocyte glycoprotein antibody-associated disease. J Neurol Neurosurg Psychiatry. 2024 Jul 4 Epub 2024 July 04
    View PubMed
  11. Hagbohm C, Ouellette R, Flanagan EP, Jonsson DI, Piehl F, Banwell B, Wickstrom R, Iacobaeus E, Granberg T, Ineichen BV. Clinical and neuroimaging phenotypes of autoimmune glial fibrillary acidic protein astrocytopathy: A systematic review and meta-analysis. Eur J Neurol. 2024 Jul; 31 (7):e16284 Epub 2024 Mar 20
    View PubMed
  12. Syc-Mazurek SB, Zhao-Fleming H, Guo Y, Tisavipat N, Chen JJ, Zekeridou A, Kournoutas I, Orme JJ, Block MS, Lucchinetti CF, Mustafa R, Flanagan EP. MOG Antibody-Associated Disease in the Setting of Metastatic Melanoma Complicated by Immune Checkpoint Inhibitor Use. Neurol Neuroimmunol Neuroinflamm. 2024 Jul; 11 (4):e200249 Epub 2024 May 02
    View PubMed
  13. Redenbaugh V, Fryer JP, Cacciaguerra L, Chen JJ, Greenwood TM, Gilligan M, Thakolwiboon S, Majed M, Chia NH, McKeon A, Mills JR, Lopez Chiriboga AS, Tillema JM, Yang B, Abdulrahman Y, Guo K, Vorasoot N, Valencia Sanchez C, Tajfirouz DA, Toledano M, Zekeridou A, Dubey D, Gombolay GY, Caparo-Zamalloa C, Kister I, Pittock SJ, Flanagan EP. Diagnostic Utility of MOG Antibody Testing in Cerebrospinal Fluid. Ann Neurol. 2024 Jul; 96 (1):34-45 Epub 2024 Apr 09
    View PubMed
  14. Estrela T, Stiebel-Kalish H, Rettenmaier L, Henderson AD, Sotirchos E, Said Y, Ahmadi G, Tajfirouz DA, Flanagan EP, Tisavipat N, Gise R, Chwalisz BK, Chen JJ. Optic Disc Cupping in Neuromyelitis Optica Spectrum Disorder, Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, and Multiple Sclerosis and Its Relationship With Optical Coherence Tomography Parameters: A Multicenter Study. J Neuroophthalmol. 2024 Jul 1 Epub 2024 July 01
    View PubMed
  15. Pluvinage JV, Ngo T, Fouassier C, McDonagh M, Holmes BB, Bartley CM, Kondapavulur S, Hurabielle C, Bodansky A, Pai V, Hinman S, Aslanpour A, Alvarenga BD, Zorn KC, Zamecnik C, McCann A, Asencor AI, Huynh T, Browne W, Tubati A, Haney MS, Douglas VC, Louine M, Cree BAC, Hauser SL, Seeley W, Baranzini SE, Wells JA, Spudich S, Farhadian S, Ramachandran PS, Gillum L, Hales CM, Zikherman J, Anderson MS, Yazdany J, Smith B, Nath A, Suh G, Flanagan EP, Green AJ, Green R, Gelfand JM, DeRisi JL, Pleasure SJ, Wilson MR. Transcobalamin receptor antibodies in autoimmune vitamin B12 central deficiency. Sci Transl Med. 2024 Jun 26; 16 (753):eadl3758 Epub 2024 June 26
    View PubMed
  16. Nathoo N, Uhm JH, Porter AB, Hammack J, Jaeckle KA, Mrugala MM, Crum BA, Flanagan EP, Pittock SJ, Goyal G, Young JR, Koster MJ, Vassallo R, Ryu JH, Davidge-Pitts CJ, Bach C, Ravindran A, Sartori Valinotti JC, Bennani NN, Abeykoon JP, Shah MV, Hook CC, Rech KL, Go RS, Tobin WO, Mayo Clinic-University of Alabama at Birmingham Histiocytosis Working Group. Clinical features and outcomes in primary nervous system histiocytic neoplasms. Blood Cancer J 2024 Jun 20; 14 (1):101 Epub 2024 June 20
    View PubMed
  17. Kraker JA, Xu SC, Flanagan EP, Foster R, Wang F, Chen JJ. Ocular Manifestations of Multiple Sclerosis: A Population-Based Study. J Neuroophthalmol. 2024 Jun 1; 44 (2):157-161 Epub 2024 Mar 08
    View PubMed
  18. Mangioris G, Halfdanarson TR, Lennon VA, Chang BK, Dubey D, Dyck PJB, Flanagan EP, McKeon A, Mills JR, Pittock SJ, Zekeridou A. Neurological autoimmunity in patients with non-pulmonary neuroendocrine neoplasms: clinical manifestations and neural autoantibody profiles. Eur J Neurol. 2024 Jun; 31 (6):e16273 Epub 2024 Mar 11
    View PubMed
  19. Li X, Gupta P, Smith KM, Madhavan A, Rezk M, Zekeridou A, Flanagan EP, McKeon A, Pittock SJ, Britton JW, Dubey D. Seizure-Related Falls and Near Falls in LGI1-IgG Autoimmune Encephalitis. Neurol Clin Pract. 2024 Jun; 14 (3):e200301 Epub 2024 May 07
    View PubMed
  20. Cacciaguerra L, Abdel-Mannan O, Champsas D, Mankad K, Krecke KN, Chen JJ, Syc-Mazurek SB, Redenbaugh V, Lopez-Chiriboga AS, Valencia-Sanchez C, Hemingway C, Tillema JM, Ciccarelli O, Pittock SJ, Hacohen Y, Flanagan EP. Radiologic Lag and Brain MRI Lesion Dynamics During Attacks in MOG Antibody-Associated Disease. Neurology. 2024 May 28; 102 (10):e209303 Epub 2024 May 06
    View PubMed
  21. Flanagan EP. Aspergillus myelitis: Breaking the mold to make a diagnosis. Mult Scler 2024 May; 30 (6):758-759 Epub 2024 Mar 07
    View PubMed
  22. Kelly MJ, Grant E, Murchison AG, Binks S, Ramanathan S, Michael S, Handel AE, Handunnetthi L, Uy CE, Soltys JN, Dubey D, Day GS, Lopez-Chiriboga AS, Flanagan EP, Sheerin F, Irani SR. Magnetic Resonance Imaging Characteristics of LGI1-Antibody and CASPR2-Antibody Encephalitis. JAMA Neurol. 2024 May 1; 81 (5):525-533
    View PubMed
  23. Tisavipat N, Stiebel-Kalish H, Palevski D, Bialer OY, Moss HE, Chaitanuwong P, Padungkiatsagul T, Henderson AD, Sotirchos ES, Singh S, Salman AR, Tajfirouz DA, Chodnicki KD, Pittock SJ, Flanagan EP, Chen JJ. Acute Optic Neuropathy in Older Adults: Differentiating Between MOGAD Optic Neuritis and Nonarteritic Anterior Ischemic Optic Neuropathy. Neurol Neuroimmunol Neuroinflamm. 2024 May; 11 (3):e200214 Epub 2024 Mar 28
    View PubMed
  24. Pinto E Vairo F, Kemppainen JL, Vitek CRR, Whalen DA, Kolbert KJ, Sikkink KJ, Kroc SA, Kruisselbrink T, Shupe GF, Knudson AK, Burke EM, Loftus EC, Bandel LA, Prochnow CA, Mulvihill LA, Thomas B, Gable DM, Graddy CB, Garzon GGM, Ekpoh IU, Porquera EMC, Fervenza FC, Hogan MC, El Ters M, Warrington KJ, Davis JM 3rd, Koster MJ, Orandi AB, Basiaga ML, Vella A, Kumar S, Creo AL, Lteif AN, Pittock ST, Tebben PJ, Abate EG, Joshi AY, Ristagno EH, Patnaik MS, Schimmenti LA, Dhamija R, Sabrowsky SM, Wierenga KJ, Keddis MT, Samadder NJJ, Presutti RJ, Robinson SI, Stephens MC, Roberts LR, Faubion WA Jr, Driscoll SW, Wong-Kisiel LC, Selcen D, Flanagan EP, Ramanan VK, Jackson LM, Mauermann ML, Ortega VE, Anderson SA, Aoudia SL, Klee EW, McAllister TM, Lazaridis KN. Correction: Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD). J Transl Med. 2024 Apr 30; 22 (1):400
    View PubMed
  25. Gupta P, Paul P, Redenbaugh V, Guo Y, Lucchinetti C, Abdulrahman Y, Datta A, Shah S, Klein CJ, Pittock SJ, Flanagan EP, Dubey D. Peripheral nervous system manifestations of MOG antibody associated disease. Ann Clin Transl Neurol. 2024 Apr; 11 (4):1046-1052 Epub 2024 Jan 17
    View PubMed
  26. Budhram A, Irani SR, Flanagan EP. Looking Beyond Syndrome-Based Criteria for Autoimmune Encephalitis-The Need for Complementary Neural Antibody-Based Diagnostic Criteria. JAMA Neurol. 2024 Mar 1; 81 (3):227-228
    View PubMed
  27. Cacciaguerra L, Flanagan EP. Updates in NMOSD and MOGAD Diagnosis and Treatment: A Tale of Two Central Nervous System Autoimmune Inflammatory Disorders. Neurol Clin. 2024 Feb; 42 (1):77-114 Epub 2023 Aug 07
    View PubMed
  28. Carta S, Dinoto A, Capobianco M, Valentino P, Montarolo F, Sala A, Reindl M, Lo Re M, Chiodega V, Branger P, Audoin B, Aboab J, Papeix C, Collongues N, Kerschen P, Zephir H, Creange A, Bourre B, Schanda K, Flanagan EP, Redenbaugh V, Villacieros-Alvarez J, Arrambide G, Cobo-Calvo A, Ferrari S, Marignier R, Mariotto S. Serum Biomarker Profiles Discriminate AQP4 Seropositive and Double Seronegative Neuromyelitis Optica Spectrum Disorder. Neurol Neuroimmunol Neuroinflamm. 2024 Jan; 11 (1):e200188 Epub 2023 Dec 22
    View PubMed
  29. Montalvo M, Flanagan EP. Paraneoplastic/autoimmune myelopathies. Handb Clin Neurol. 2024; 200:193-201
    View PubMed
  30. Budhram A, Flanagan EP. Optimizing the diagnostic performance of neural antibody testing for paraneoplastic and autoimmune encephalitis in clinical practice. Handb Clin Neurol. 2024; 200:365-382
    View PubMed
  31. Flanagan EP, Dubey D. Autoimmune neuromuscular disorders associated with neural antibodies. CONTINUUM Lifelong Learning in Neurology. 2024; 30 (4):1136-59
  32. Samadzadeh S, Adnan R, Berglova P, Barzegar M, Debrabant B, Roikjaer SG, Levy M, Petzold A, Palace J, Flanagan EP, Mariotto S, Skou ST, Froelich A, Lotan I, Messina S, Geraldes R, Asseyer S, Stiebel-Kalish H, Oertel FC, Shaygannejad V, Sahraian MA, Kim HJ, Bennett JL, Bottcher C, Zimmermann HG, Weinshenker BG, Paul F, Asgari N. Protocol of a prospective multicenter study on comorbidity impact on multiple sclerosis and antibody-mediated diseases of the central nervous system (COMMIT). Front Immunol. 2024; 15:1380025 Epub 2024 July 02
    View PubMed
  33. Elsbernd P, Cacciaguerra L, Krecke KN, Chen JJ, Gritsch D, Lopez-Chiriboga AS, Sechi E, Redenbaugh V, Morris PP, Carter JL, Wingerchuk DM, Tillema JM, Valencia-Sanchez C, Thakolwiboon S, Pittock SJ, Flanagan EP. Cerebral enhancement in MOG antibody-associated disease. J Neurol Neurosurg Psychiatry. 2023 Dec 14; 95 (1):14-18
    View PubMed
  34. Rode MM, Itoh C, Martinez-Sosa S, Ebner BA, Chang BK, Flanagan EP, Pinto MV. Systematic approach to diagnosing suspected Creutzfeldt-Jakob disease. BMJ Case Rep. 2023 Dec 7; 16 (12) Epub 2023 Dec 07
    View PubMed
  35. Samadzadeh S, Olesen MN, Wirenfeldt M, Moller S, Misu T, Soelberg K, Frederiksen JL, Heegaard S, Mariotto S, Fujihara K, Ruprecht K, Andersen TL, Marignier R, Lillevang ST, Flanagan EP, Pittock SJ, Kim HJ, Bennett JL, Paul F, Sorensen GL, Weinshenker BG, Lassmann H, Asgari N. Microfibrillar-associated protein 4 as a potential marker of acute relapse in inflammatory demyelinating diseases of the central nervous system: Pathological and clinical aspects. Mult Scler. 2023 Dec; 29 (14):1721-1735 Epub 2023 Oct 13
    View PubMed
  36. Cohen DA, Tajfirouz D, Vodopivec I, Kyle K, Bouffard MA, Bhattacharyya S, Douglas VC, Rasool N, Bhatti MT, McKeon A, Pittock S, Flanagan EP, Prasad S, Nagagopal V, Egan RA, Chen JJ, Chwalisz BK. Fluorescein Angiography Findings in Susac Syndrome: A Multicenter Retrospective Case Series. J Neuroophthalmol. 2023 Dec 1; 43 (4):481-490 Epub 2023 Apr 19
    View PubMed
  37. Li X, Krecke KN, Weinshenker BG, Clarke MJ, Zekeridou A, Toledano M, Flanagan EP. Hemicord White Matter Enhancement and the Croissant Sign in Cervical Spondylotic Myelopathy. Neurology. 2023 Nov 21; 101 (21):968-969 Epub 2023 Aug 30
    View PubMed
  38. Griffin KJ, Toledano M, Flanagan EP, Mustafa R. "Trident Sign" in Primary CNS B-Cell Spinal Cord Lymphoma. Neurology. 2023 Nov 7; 101 (19):857-858 Epub 2023 Aug 30
    View PubMed
  39. Mustafa R, Flanagan EP, Duffy DJ, Weinshenker BG, Soldan MMP, Kunchok A, Kaisey M, Solomon AJ. Laboratory evaluation for the differential diagnosis of possible multiple sclerosis in the United States: A physician survey. J Neurol Sci. 2023 Oct 15; 453:120781 Epub 2023 Sept 01
    View PubMed
  40. Zara P, Dinoto A, Carta S, Floris V, Turilli D, Budhram A, Ferrari S, Milia S, Solla P, Mariotto S, Flanagan EP, Lopez Chiriboga AS, Sechi E. Non-demyelinating disorders mimicking and misdiagnosed as NMOSD: a literature review. Eur J Neurol. 2023 Oct; 30 (10):3367-3376 Epub 2023 July 19
    View PubMed
  41. Majed M, Valencia Sanchez C, Bennett JL, Fryer J, Mulligan MD, Redenbaugh V, McKeon A, Mills JR, Wingerchuk DM, Lennon VA, Weinshenker B, Chen JJ, Flanagan EP, Pittock SJ, Kunchok A. Alterations in Aquaporin-4-IgG Serostatus in 986 Patients: A Laboratory-Based Longitudinal Analysis. Ann Neurol. 2023 Oct; 94 (4):727-735 Epub 2023 July 05
    View PubMed
  42. Cacciaguerra L, Redenbaugh V, Chen JJ, Morris P, Sechi E, Syc-Mazurek SB, Lopez-Chiriboga AS, Tillema JM, Rocca MA, Filippi M, Pittock SJ, Flanagan EP. Timing and Predictors of T2-Lesion Resolution in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. Neurology. 2023 Sep 26; 101 (13):e1376-e1381 Epub 2023 June 19
    View PubMed
  43. McKeon A, Lesnick C, Vorasoot N, Buckley MW, Dasari S, Flanagan EP, Gilligan M, Lafrance-Corey R, Miske R, Pittock SJ, Scharf M, Yang B, Zekeridou A, Dubey D, Mills J. Utility of Protein Microarrays for Detection of Classified and Novel Antibodies in Autoimmune Neurologic Disease. Neurol Neuroimmunol Neuroinflamm. 2023 Sep; 10 (5) Epub 2023 Aug 07
    View PubMed
  44. Fereidan-Esfahani M, Decker PA, Weigand SD, Lopez Chiriboga AS, Flanagan EP, Tillema JM, Lucchinetti CF, Eckel-Passow JE, Tobin WO. Defining the natural history of tumefactive demyelination: A retrospective cohort of 257 patients. Ann Clin Transl Neurol. 2023 Sep; 10 (9):1544-1555 Epub 2023 July 13
    View PubMed
  45. Smith KM, Britton JW, Thakolwiboon S, Chia NH, Gupta P, Flanagan EP, Zekeridou A, Lopez Chiriboga AS, Valencia Sanchez C, McKeon A, Pittock SJ, Dubey D. Seizure characteristics and outcomes in patients with neurological conditions related to high-risk paraneoplastic antibodies. Epilepsia. 2023 Sep; 64 (9):2385-2398 Epub 2023 July 04
    View PubMed
  46. Chen B, Gomez-Figueroa E, Redenbaugh V, Francis A, Satukijchai C, Wu Y, Messina S, Sa M, Woodhall M, Paul F, Robertson NP, Lim M, Wassmer E, Kneen R, Huda S, Blain C, Halfpenny C, Hemingway C, O'Sullivan E, Hobart J, Fisniku LK, Martin RJ, Dobson R, Cooper SA, Williams V, Waters P, Chen JJ, Pittock SJ, Ramdas S, Leite MI, Flanagan EP, Geraldes R, Palace J. Do Early Relapses Predict the Risk of Long-Term Relapsing Disease in an Adult and Paediatric Cohort with MOGAD? Ann Neurol. 2023 Sep; 94 (3):508-517 Epub 2023 July 12
    View PubMed
  47. Chen JJ, Flanagan EP, Pittock SJ, Stern NC, Tisavipat N, Bhatti MT, Chodnicki KD, Tajfirouz DA, Jamali S, Kunchok A, Eggenberger ER, Nome MAD, Sotirchos ES, Vasileiou ES, Henderson AD, Arnold AC, Bonelli L, Moss HE, Navarro SEV, Padungkiatsagul T, Stiebel-Kalish H, Lotan I, Wilf-Yarkoni A, Danesh-Meyer H, Ivanov S, Huda S, Forcadela M, Hodge D, Poullin P, Rode J, Papeix C, Saheb S, Boudot de la Motte M, Vignal C, Hacohen Y, Pique J, Maillart E, Deschamps R, Audoin B, Marignier R. Visual Outcomes Following Plasma Exchange for Optic Neuritis: An International Multicenter Retrospective Analysis of 395 Optic Neuritis Attacks. Am J Ophthalmol. 2023 Aug; 252:213-224 Epub 2023 Feb 21
    View PubMed
  48. Solomon AJ, Arrambide G, Brownlee WJ, Flanagan EP, Amato MP, Amezcua L, Banwell BL, Barkhof F, Corboy JR, Correale J, Fujihara K, Graves J, Harnegie MP, Hemmer B, Lechner-Scott J, Marrie RA, Newsome SD, Rocca MA, Royal W 3rd, Waubant EL, Yamout B, Cohen JA. Differential diagnosis of suspected multiple sclerosis: an updated consensus approach. Lancet Neurol. 2023 Aug; 22 (8):750-768
    View PubMed
  49. Lotan I, Chen JJ, Hacohen Y, Abdel-Mannan O, Mariotto S, Huda S, Gibbons E, Wilf-Yarkoni A, Hellmann MA, Stiebel-Kalish H, Pittock SJ, Flanagan EP, Molazadeh N, Anderson M, Salky R, Romanow G, Schindler P, Duchow AS, Paul F, Levy M. Intravenous immunoglobulin treatment for acute attacks in myelin oligodendrocyte glycoprotein antibody disease. Mult Scler. 2023 Aug; 29 (9):1080-1089 Epub 2023 July 10
    View PubMed
  50. Valencia-Sanchez C, Sechi E, Dubey D, Flanagan EP, McKeon A, Pittock SJ, Zekeridou A. Immune checkpoint inhibitor-associated central nervous system autoimmunity. Eur J Neurol. 2023 Aug; 30 (8):2418-2429 Epub 2023 May 18
    View PubMed
  51. Webb LM, Cacciaguerra L, Krecke KN, Chen JJ, Sechi E, Redenbaugh V, Dubey D, Pittock SJ, Flanagan EP. Marked central canal T2-hyperintensity in MOGAD myelitis and comparison to NMOSD and MS. J Neurol Sci. 2023 Jul 15; 450:120687 Epub 2023 May 12
    View PubMed
  52. Chia NH, McKeon A, Dalakas MC, Flanagan EP, Bower JH, Klassen BT, Dubey D, Zalewski NL, Duffy D, Pittock SJ, Zekeridou A. Stiff person spectrum disorder diagnosis, misdiagnosis, and suggested diagnostic criteria. Ann Clin Transl Neurol. 2023 Jul; 10 (7):1083-1094 Epub 2023 May 22
    View PubMed
  53. Meiling JB, Ha CT, Garlanger KL, Snider BA, Flanagan EP, Reeves RK. Inpatient rehabilitation outcomes in patients with the new diagnosis of COVID-19 tractopathy: a case series. Spinal Cord Ser Cases. 2023 Jul 1; 9 (1):25 Epub 2023 July 01
    View PubMed
  54. Tisavipat N, Chang BK, Ali F, Pittock SJ, Kammeyer R, Declusin A, Cohn SJ, Flanagan EP. Subacute Horizontal Diplopia, Jaw Dystonia, and Laryngospasm. Neurol Neuroimmunol Neuroinflamm. 2023 Jul; 10 (4) Epub 2023 June 13
    View PubMed
  55. Flanagan EP, Waters PJ. Serum MOG-IgG titers should be performed routinely in the diagnosis and follow-up of MOGAD: No. Mult Scler. 2023 Jul; 29 (8):928-929 Epub 2023 May 25
    View PubMed
  56. Pinto E Vairo F, Kemppainen JL, Vitek CRR, Whalen DA, Kolbert KJ, Sikkink KJ, Kroc SA, Kruisselbrink T, Shupe GF, Knudson AK, Burke EM, Loftus EC, Bandel LA, Prochnow CA, Mulvihill LA, Thomas B, Gable DM, Graddy CB, Garzon GGM, Ekpoh IU, Porquera EMC, Fervenza FC, Hogan MC, El Ters M, Warrington KJ, Davis JM 3rd, Koster MJ, Orandi AB, Basiaga ML, Vella A, Kumar S, Creo AL, Lteif AN, Pittock ST, Tebben PJ, Abate EG, Joshi AY, Ristagno EH, Patnaik MS, Schimmenti LA, Dhamija R, Sabrowsky SM, Wierenga KJ, Keddis MT, Samadder NJJ, Presutti RJ, Robinson SI, Stephens MC, Roberts LR, Faubion WA Jr, Driscoll SW, Wong-Kisiel LC, Selcen D, Flanagan EP, Ramanan VK, Jackson LM, Mauermann ML, Ortega VE, Anderson SA, Aoudia SL, Klee EW, McAllister TM, Lazaridis KN. Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD). J Transl Med. 2023 Jun 23; 21(1):410.
    View PubMed
  57. Yandamuri SS, Filipek B, Obaid AH, Lele N, Thurman JM, Makhani N, Nowak RJ, Guo Y, Lucchinetti CF, Flanagan EP, Longbrake EE, O'Connor KC. MOGAD patient autoantibodies induce complement, phagocytosis, and cellular cytotoxicity. JCI Insight. 2023 Jun 8; 8 (11) Epub 2023 June 08
    View PubMed
  58. Redenbaugh V, Chia NH, Cacciaguerra L, McCombe JA, Tillema JM, Chen JJ, Lopez Chiriboga AS, Sechi E, Hacohen Y, Pittock SJ, Flanagan EP. Comparison of MRI T2-lesion evolution in pediatric MOGAD, NMOSD, and MS. Mult Scler. 2023 Jun; 29 (7):799-808 Epub 2023 May 23
    View PubMed
  59. Orozco E, Valencia-Sanchez C, Britton J, Dubey D, Flanagan EP, Lopez-Chiriboga AS, Zalewski N, Zekeridou A, Pittock SJ, McKeon A. Autoimmune Encephalitis Criteria in Clinical Practice. Neurol Clin Pract. 2023 Jun; 13(3):e200151. Epub 2023 Apr 25.
    View PubMed
  60. Ziaei A, Nasr Z, Hart J, Francisco C, Rutatangwa A, Leppert D, Kuhle J, Flanagan E, Waubant E. High serum neurofilament levels are observed close to disease activity events in pediatric-onset MS and MOG antibody-associated diseases. Mult Scler Relat Disord. 2023 Jun; 74:104704 Epub 2023 Apr 03
    View PubMed
  61. Dinoto A, Zara P, Mariotto S, Ferrari S, Flanagan EP, Budhram A, Orellana D, Turilli D, Solla P, Day GS, Sechi E, Lopez-Chiriboga AS. Autoimmune encephalitis misdiagnosis and mimics. J Neuroimmunol. 2023 May 15; 378:578071 Epub 2023 Mar 16
    View PubMed
  62. Rizzo SA, Flanagan EP, Trejo-Lopez JA, Toledano M, Chia NH. Clinical Reasoning: New-Onset Diplopia and Headache in a Patient With Metastatic Breast Cancer. Neurology. 2023 May 9; 100 (19):927-931 Epub 2023 Feb 20
    View PubMed
  63. Chia NH, Redenbaugh V, Chen JJ, Pittock SJ, Flanagan EP. Corpus callosum involvement in MOG antibody-associated disease in comparison to AQP4-IgG-seropositive neuromyelitis optica spectrum disorder and multiple sclerosis. Mult Scler. 2023 May; 29 (6):748-752 Epub 2023 Jan 24
    View PubMed
  64. Tisavipat N, Flanagan EP. Current perspectives on the diagnosis and management of acute transverse myelitis. Expert Rev Neurother. 2023 Apr; 23 (4):389-411 Epub 2023 Apr 07
    View PubMed
  65. Cacciaguerra L, Morris P, Tobin WO, Chen JJ, Banks SA, Elsbernd P, Redenbaugh V, Tillema JM, Montini F, Sechi E, Lopez-Chiriboga AS, Zalewski N, Guo Y, Rocca MA, Filippi M, Pittock SJ, Lucchinetti CF, Flanagan EP. Tumefactive Demyelination in MOG Ab-Associated Disease, Multiple Sclerosis, and AQP-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder. Neurology. 2023 Mar 28; 100 (13):e1418-e1432 Epub 2023 Jan 23
    View PubMed
  66. Carta S, Cobo Calvo A, Armangue T, Saiz A, Lechner C, Rostasy K, Breu M, Baumann M, Hoftberger R, Ayzenberg I, Schwake C, Sepulveda M, Martinez-Hernandez E, Olive-Cirera G, Arrambide G, Tintore M, Bernard-Valnet R, Du Pasquier R, Brilot F, Ramanathan S, Schanda K, Gajofatto A, Ferrari S, Sechi E, Flanagan EP, Pittock SJ, Redenbaugh V, Reindl M, Marignier R, Mariotto S. Significance of Myelin Oligodendrocyte Glycoprotein Antibodies in CSF: A Retrospective Multicenter Study. Neurology. 2023 Mar 14; 100 (11):e1095-e1108 Epub 2022 Dec 16
    View PubMed
  67. Banwell B, Bennett JL, Marignier R, Kim HJ, Brilot F, Flanagan EP, Ramanathan S, Waters P, Tenembaum S, Graves JS, Chitnis T, Brandt AU, Hemingway C, Neuteboom R, Pandit L, Reindl M, Saiz A, Sato DK, Rostasy K, Paul F, Pittock SJ, Fujihara K, Palace J. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria. Lancet Neurol. 2023 Mar; 22 (3):268-282 Epub 2023 Jan 24
    View PubMed
  68. Stiebel-Kalish H, Rubarth K, Shouchane-Blum K, Tiosano A, Lotan I, Hellmann MA, Wilf-Yarkoni A, Bialer O, Flanagan EP, Pittock SJ, Bhatti MT, Schmitz-Hubsch T, Paul F, Asseyer S, Chen JJ. Author Correction: Obesity is associated with myelin oligodendrocyte glycoprotein antibody-associated disease in acute optic neuritis. Sci Rep. 2023 Feb 20; 13 (1):2944
    View PubMed
  69. McCombe JA, Zivelonghi C, Vorasoot N, Majed M, Flanagan EP, Dubey D, Pittock SJ, McKeon A, Zekeridou A. AMPAR autoimmunity: Neurological and oncological accompaniments and co-existing neural autoantibodies. J Neuroimmunol. 2023 Feb 15; 375:578012 Epub 2022 Dec 23
    View PubMed
  70. Valencia-Sanchez C, Guo Y, Krecke KN, Chen JJ, Redenbaugh V, Montalvo M, Elsbernd PM, Tillema JM, Lopez-Chiriboga S, Budhram A, Sechi E, Kunchok A, Dubey D, Pittock SJ, Lucchinetti CF, Flanagan EP. Cerebral Cortical Encephalitis in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. Ann Neurol. 2023 Feb; 93 (2):297-302 Epub 2022 Dec 02
    View PubMed
  71. Gaudioso CM, Mar S, Casper TC, Codden R, Nguyen A, Aaen G, Benson L, Chitnis T, Francisco C, Gorman MP, Goyal MS, Graves J, Greenberg BM, Hart J, Krupp L, Lotze T, Narula S, Pittock SJ, Rensel M, Rodriguez M, Rose J, Schreiner T, Tillema JM, Waldman A, Weinstock-Guttman B, Wheeler Y, Waubant E, Flanagan EP, United States Network of Pediatric Multiple Sclerosis Centers. MOG and AQP4 Antibodies among Children with Multiple Sclerosis and Controls. Ann Neurol. 2023 Feb; 93 (2):271-284 Epub 2022 Oct 04
    View PubMed
  72. Fautsch KJ, Block DR, Graff-Radford J, Wang F, Craver EC, Hodge DO, Cutsforth-Gregory JK, Kilgore KP, Petersen RC, Knopman DS, Flanagan E, Toledano M, Mielke MM, Bhatti MT, Chen JJ. Population-Based Evaluation of Total Protein in Cerebrospinal Fluid. Mayo Clin Proc. 2023 Feb; 98 (2):239-251
    View PubMed
  73. Flanagan EP, Geschwind MD, Lopez-Chiriboga AS, Blackburn KM, Turaga S, Binks S, Zitser J, Gelfand JM, Day GS, Dunham SR, Rodenbeck SJ, Clardy SL, Solomon AJ, Pittock SJ, McKeon A, Dubey D, Zekeridou A, Toledano M, Turner LE, Vernino S, Irani SR. Autoimmune Encephalitis Misdiagnosis in Adults. JAMA Neurol. 2023 Jan 1; 80 (1):30-39
    View PubMed
  74. Jackson-Tarlton CS, Flanagan EP, Messina SA, Barakat B, Ahmad R, Kantarci OH, Weinshenker BG, Keegan BM. Progressive motor impairment from "critical" demyelinating lesions of the cervicomedullary junction. Mult Scler. 2023 Jan; 29 (1):74-80 Epub 2022 Aug 24
    View PubMed
  75. Asseyer S, Asgari N, Bennett J, Bialer O, Blanco Y, Bosello F, Camos-Carreras A, Carnero Contentti E, Carta S, Chen J, Chien C, Chomba M, Dale RC, Dalmau J, Feldmann K, Flanagan EP, Froment Tilikete C, Garcia-Alfonso C, Havla J, Hellmann M, Kim HJ, Klyscz P, Konietschke F, La Morgia C, Lana-Peixoto M, Leite MI, Levin N, Levy M, Llufriu S, Lopez P, Lotan I, Lugaresi A, Marignier R, Mariotto S, Mollan SP, Ocampo C, Cosima Oertel F, Olszewska M, Palace J, Pandit L, Peralta Uribe JL, Pittock S, Ramanathan S, Rattanathamsakul N, Saiz A, Samadzadeh S, Sanchez-Dalmau B, Saylor D, Scheel M, Schmitz-Hubsch T, Shifa J, Siritho S, Sperber PS, Subramanian PS, Tiosano A, Vaknin-Dembinsky A, Mejia Vergara AJ, Wilf-Yarkoni A, Zarco LA, Zimmermann HG, Paul F, Stiebel-Kalish H. The Acute Optic Neuritis Network (ACON): Study protocol of a non-interventional prospective multicenter study on diagnosis and treatment of acute optic neuritis. Front Neurol. 2023; 14:1102353 Epub 2023 Feb 24
    View PubMed
  76. Flanagan EP, Geschwind MD, Lopez-Chiriboga AS, Blackburn KM, Turaga S, Binks S, Zitser J, Gelfand JM, Day GS, Dunham SR, Rodenbeck SJ, Clardy SL, Solomon AJ, Pittock SJ, McKeon A, Dubey D, Zekeridou A, Toledano M, Turner LE, Vernino S, Irani SR. Autoimmune Encephalitis Misdiagnosis in Adults. JAMA Neurol. 2023 Jan 1; 80(1):30-39. Epub 1900 Jan 01.
    View PubMed
  77. Stiebel-Kalish H, Rubarth K, Shouchane-Blum K, Tiosano A, Lotan I, Hellmann MA, Wilf-Yarkoni A, Bialer O, Flanagan EP, Pittock SJ, Bhatti MT, Schmitz-Hubsch T, Paul F, Asseyer S, Chen JJ. Obesity is associated with myelin oligodendrocyte glycoprotein antibody-associated disease in acute optic neuritis. Sci Rep. 2022 Dec 9; 12 (1):21312 Epub 2022 Dec 09
    View PubMed
  78. Mustafa R, Zalewski NL, Flanagan EP, Kumar N. Challenging Myelopathy Cases. Semin Neurol. 2022 Dec; 42 (6):723-734 Epub 2022 Nov 23
    View PubMed
  79. Montalvo M, Khattak JF, Redenbaugh V, Britton J, Valencia Sanchez C, Sanchez CV, Datta A, Tillema JM, Chen J, McKeon A, Pittock SJ, Flanagan EP, Dubey D. Acute symptomatic seizures secondary to myelin oligodendrocyte glycoprotein antibody-associated disease. Epilepsia. 2022 Dec; 63 (12):3180-3191 Epub 2022 Oct 14
    View PubMed
  80. Chen JJ, Flanagan EP, Bhatti MT, Tisavipat N, Jamali S, Kunchok A, Eggenberger ER, Nome MD, Sotirchos ES, Vasileiou ES, Henderson AD, Arnold AC, Bonelli L, Seleme N, Mejia-Vergara AJ, Moss HE, Padungkiatsagul T, Stiebel-Kalish H, Lotan I, Wilf-Yarkoni A, Hellmann MA, Vuppala A, Hodge D, Pittock SJ. Details and outcomes of a large cohort of MOG-IgG associated optic neuritis. Mult Scler Relat Disord. 2022 Dec; 68:104237. Epub 2022 Oct 10.
    View PubMed
  81. Syc-Mazurek SB, Chen JJ, Morris P, Sechi E, Mandrekar J, Tillema JM, Lopez-Chiriboga AS, Lucchinetti CF, Zalewski N, Cacciaguerra L, Buciuc M, Krecke KN, Messina SA, Bhatti MT, Pittock SJ, Flanagan EP. Frequency of New or Enlarging Lesions on MRI Outside of Clinical Attacks in Patients With MOG-Antibody-Associated Disease. Neurology. 2022 Oct 31; 99 (18):795-799
    View PubMed
  82. Chang BK, Day GS, Graff-Radford J, McKeon A, Flanagan EP, Algeciras-Schimnich A, Mielke MM, Nguyen A, Jones DT, Toledano M, Kremers WK, Knopman DS, Petersen RC, Li W. Alzheimer's disease cerebrospinal fluid biomarkers differentiate patients with Creutzfeldt-Jakob disease and autoimmune encephalitis. Eur J Neurol. 2022 Oct; 29 (10):2905-2912 Epub 2022 July 05
    View PubMed
  83. Hardy TA, Guo Y, Flanagan EP, Lucchinetti CF, Tobin WO. The clinical spectrum of haemorrhagic CNS inflammatory demyelinating lesions. Mult Scler. 2022 Oct; 28 (11):1710-1718 Epub 2022 May 17
    View PubMed
  84. Saadeh RS, Ramos PA, Algeciras-Schimnich A, Flanagan EP, Pittock SJ, Willrich MA. An Update on Laboratory-Based Diagnostic Biomarkers for Multiple Sclerosis and Beyond. Clin Chem. 2022 Sep 1; 68 (9):1134-1150
    View PubMed
  85. Oertel FC, Sotirchos ES, Zimmermann HG, Motamedi S, Specovius S, Asseyer ES, Chien C, Cook L, Vasileiou E, Filippatou A, Calabresi PA, Saidha S, Pandit L, D'Cunha A, Outteryck O, Zephir H, Pittock S, Flanagan EP, Bhatti MT, Rommer PS, Bsteh G, Zrzavy T, Kuempfel T, Aktas O, Ringelstein M, Albrecht P, Ayzenberg I, Pakeerathan T, Knier B, Aly L, Asgari N, Soelberg K, Marignier R, Tilikete CF, Cobo Calvo A, Villoslada P, Sanchez-Dalmau B, Martinez-Lapiscina EH, Llufriu S, Green AJ, Yeaman MR, Smith TJ, Brandt AU, Chen J, Paul F, Havla J, with the GJCF International Clinical Consortium for NMOSD and the CROCTINO study group. Longitudinal Retinal Changes in MOGAD. Ann Neurol. 2022 Sep; 92 (3):476-485 Epub 2022 July 16
    View PubMed
  86. Hur M, Madhavan AA, Hodge DO, Eckel LJ, Pittock SJ, Flanagan EP, Bhatti MT, Chen JJ. Comparison of 1.5 Tesla and 3.0 Tesla Magnetic Resonance Imaging in the Evaluation of Acute Demyelinating Optic Neuritis. J Neuroophthalmol. 2022 Sep 1; 42 (3):297-302 Epub 2022 July 13
    View PubMed
  87. Shah SS, Morris P, Buciuc M, Tajfirouz D, Wingerchuk DM, Weinshenker BG, Eggenberger ER, Di Nome M, Pittock SJ, Flanagan EP, Bhatti MT, Chen JJ. Frequency of Asymptomatic Optic Nerve Enhancement in a Large Retrospective Cohort of Patients With Aquaporin-4+ NMOSD. Neurology. 2022 Aug 23; 99 (8):e851-e857 Epub 2022 June 13
    View PubMed
  88. Zekeridou A, Yang B, Lennon VA, Guo Y, Wu L, Lucchinetti CF, McKeon A, Pittock SJ, Flanagan EP. Anti-Neuronal Nuclear Antibody 3 Autoimmunity Targets Dachshund Homolog 1. Ann Neurol. 2022 May; 91 (5):670-675 Epub 2022 Mar 03
    View PubMed
  89. Chen JJ, Huda S, Hacohen Y, Levy M, Lotan I, Wilf-Yarkoni A, Stiebel-Kalish H, Hellmann MA, Sotirchos ES, Henderson AD, Pittock SJ, Bhatti MT, Eggenberger ER, Di Nome M, Kim HJ, Kim SH, Saiz A, Paul F, Dale RC, Ramanathan S, Palace J, Camera V, Leite MI, Lam BL, Bennett JL, Mariotto S, Hodge D, Audoin B, Maillart E, Deschamps R, Pique J, Flanagan EP, Marignier R. Association of Maintenance Intravenous Immunoglobulin With Prevention of Relapse in Adult Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. JAMA Neurol. 2022 May 1; 79 (5):518-525
    View PubMed
  90. Syc-Mazurek SB, Montenegro M, Clarke MJ, Flanagan EP. MRI with neck extension to diagnose cervical spondylotic myelopathy. Pract Neurol. 2022 Apr; 22 (2):162-163 Epub 2021 Nov 26
    View PubMed
  91. Redenbaugh V, Flanagan EP. Monoclonal Antibody Therapies Beyond Complement for NMOSD and MOGAD. Neurotherapeutics. 2022 Apr; 19 (3):808-822 Epub 2022 Mar 10
    View PubMed
  92. Shah S, Flanagan EP, Paul P, Smith CY, Bryant SC, Devine MF, Lennon VA, McKeon A, Pittock SJ, Dubey D. Population-Based Epidemiology Study of Paraneoplastic Neurologic Syndromes. Neurol Neuroimmunol Neuroinflamm. 2022 Mar; 9 (2) Epub 2021 Dec 22
    View PubMed
  93. Kunchok A, McKeon A, Zekeridou A, Flanagan EP, Dubey D, Lennon VA, Klein CJ, Mills JR, Pittock SJ. Autoimmune/Paraneoplastic Encephalitis Antibody Biomarkers: Frequency, Age, and Sex Associations. Mayo Clin Proc. 2022 Mar; 97 (3):547-559 Epub 2021 Dec 23
    View PubMed
  94. Abeykoon JP, Lasho TL, Dasari S, Rech KL, Ranatunga WK, Manske MK, Tischer A, Ravindran A, Young JR, Tobin WO, Flanagan EP, Nowakowski KE, Ruan GJ, Shah MV, Bennani NN, Vassallo R, Ryu JH, Koster MJ, Davidge-Pitts CJ, Patnaik MM, Wu X, Witzig TE, Goyal G, Go RS, Mayo Clinic-University of Alabama at Birmingham Histiocytosis Working Group. Sustained, complete response to pexidartinib in a patient with CSF1R-mutated Erdheim-Chester disease. Am J Hematol. 2022 Mar 1; 97 (3):293-302 Epub 2022 Jan 03
    View PubMed
  95. Garrido Sanabria ER, Zahid A, Britton J, Kraus GJ, Lopez-Chiriboga AS, Zekeridou A, Flanagan EP, McKeon A, Mills JR, Pittock SJ, Dubey D. CASPR2-IgG-associated autoimmune seizures. Epilepsia. 2022 Mar; 63 (3):709-722 Epub 2022 Jan 15
    View PubMed
  96. Rodriguez A, Klein CJ, Sechi E, Alden E, Basso MR, Pudumjee S, Pittock SJ, McKeon A, Britton JW, Lopez-Chiriboga AS, Zekeridou A, Zalewski NL, Boeve BF, Day GS, Gadoth A, Burkholder D, Toledano M, Dubey D, Flanagan EP. LGI1 antibody encephalitis: acute treatment comparisons and outcome. J Neurol Neurosurg Psychiatry. 2022 Mar; 93 (3):309-315 Epub 2021 Nov 25
    View PubMed
  97. Fereidan-Esfahani M, Decker PA, Eckel Passow JE, Lucchinetti CF, Flanagan EP, Tobin WO. Population-based incidence and clinico-radiological characteristics of tumefactive demyelination in Olmsted County, Minnesota, United States. Eur J Neurol. 2022 Mar; 29 (3):782-789 Epub 2021 Dec 09
    View PubMed
  98. Redenbaugh V, Flanagan EP. Understanding the etiology and epidemiology of meningitis and encephalitis: now and into the future. Lancet Reg Health West Pac. 2022 Mar; 20:100380 Epub 2022 Jan 22
    View PubMed
  99. Solomon AJ, Dasari S, Flanagan EP. Teaching case in MS differential diagnosis: A Longstanding diagnosis of MS with severe disability. Mult Scler Relat Disord. 2022 Mar; 59:103540 Epub 2022 Jan 19
    View PubMed
  100. Chen JJ, Sotirchos ES, Henderson AD, Vasileiou ES, Flanagan EP, Bhatti MT, Jamali S, Eggenberger ER, Dinome M, Frohman LP, Arnold AC, Bonelli L, Seleme N, Mejia-Vergara AJ, Moss HE, Padungkiatsagul T, Stiebel-Kalish H, Lotan I, Hellmann MA, Hodge D, Oertel FC, Paul F, Saidha S, Calabresi PA, Pittock SJ. OCT retinal nerve fiber layer thickness differentiates acute optic neuritis from MOG antibody-associated disease and Multiple Sclerosis: RNFL thickening in acute optic neuritis from MOGAD vs MS. Mult Scler Relat Disord. 2022 Feb; 58:103525 Epub 2022 Jan 11
    View PubMed
  101. Londono DP, Arumaithurai K, Constantopoulos E, Basso MR, Reichard RR, Flanagan EP, Keegan BM. Diagnosis of coexistent neurodegenerative dementias in multiple sclerosis. Brain Commun. 2022; 4 (4):fcac167 Epub 2022 June 22
    View PubMed
  102. Sechi E, Cacciaguerra L, Chen JJ, Mariotto S, Fadda G, Dinoto A, Lopez-Chiriboga AS, Pittock SJ, Flanagan EP. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management. Front Neurol. 2022; 13:885218. Epub 2022 Jun 17.
    View PubMed
  103. Barakat B, Messina S, Nayak S, Kassa R, Sechi E, Flanagan EP, Kantarci O, Weinshenker BG, Keegan BM. Cerebrospinal fluid evaluation in patients with progressive motor impairment due to critical central nervous system demyelinating lesions. Mult Scler J Exp Transl Clin. 2022 Jan-Mar; 8 (1):20552173211052159 Epub 2022 Jan 12
    View PubMed
  104. Tajfirouz D, Padungkiatsagul T, Beres S, Moss HE, Pittock S, Flanagan E, Kunchok A, Shah S, Bhatti MT, Chen JJ. Optic chiasm involvement in AQP-4 antibody-positive NMO and MOG antibody-associated disorder. Mult Scler. 2022 Jan; 28 (1):149-153 Epub 2021 May 12
    View PubMed
  105. Flanagan EP, Levy M, Katz E, Cimbora D, Drappa J, Mealy MA, She D, Cree BAC. Inebilizumab for treatment of neuromyelitis optica spectrum disorder in patients with prior rituximab use from the N-MOmentum Study. Mult Scler Relat Disord. 2022 Jan; 57:103352 Epub 2021 Oct 26
    View PubMed
  106. Dinoto A, Sechi E, Flanagan EP, Ferrari S, Solla P, Mariotto S, Chen JJ. Serum and Cerebrospinal Fluid Biomarkers in Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Associated Disease. Front Neurol. 2022; 13:866824 Epub 2022 Mar 23
    View PubMed
  107. Cacciaguerra L, Sechi E, Rocca MA, Filippi M, Pittock SJ, Flanagan EP. Neuroimaging features in inflammatory myelopathies: A review. Front Neurol. 2022; 13:993645 Epub 2022 Oct 18
    View PubMed
  108. Fadda G, Flanagan EP, Cacciaguerra L, Jitprapaikulsan J, Solla P, Zara P, Sechi E. Myelitis features and outcomes in CNS demyelinating disorders: Comparison between multiple sclerosis, MOGAD, and AQP4-IgG-positive NMOSD. Front Neurol. 2022; 13:1011579 Epub 2022 Nov 07
    View PubMed
  109. Amin M, Mays M, Polston D, Flanagan EP, Prayson R, Kunchok A. Myelin oligodendrocyte glycoprotein (MOG) antibodies in a patient with glioblastoma: Red flags for false positivity. J Neuroimmunol. 2021 Dec 15; 361:577743 Epub 2021 Oct 08
    View PubMed
  110. Valencia-Sanchez C, Flanagan EP. Uncommon inflammatory/immune-related myelopathies. J Neuroimmunol. 2021 Dec 15; 361:577750 Epub 2021 Oct 13
    View PubMed
  111. Flanagan EP. Paraneoplastic disorders of the nervous system. J Neurol. 2021 Dec; 268 (12):4899-4907 Epub 2021 Apr 27
    View PubMed
  112. Thakolwiboon S, Zhao-Fleming H, Karukote A, Mao-Draayer Y, Flanagan EP, Avila M. Meta-analysis of effectiveness of steroid-sparing attack prevention in MOG-IgG-associated disorder. Mult Scler Relat Disord. 2021 Nov; 56:103310. Epub 2021 Oct 04.
    View PubMed
  113. Lui A, Chong J, Flanagan E, Abrams AW, Krysko KM, Arikan B, Francisco C, Rutatangwa A, Waubant E, Ziaei A. High titers of myelin oligodendrocyte glycoprotein antibody are only observed close to clinical events in pediatrics. Mult Scler Relat Disord. 2021 Nov; 56:103253 Epub 2021 Sept 04
    View PubMed
  114. Redenbaugh V, Montalvo M, Sechi E, Buciuc M, Fryer JP, McKeon A, Lennon VA, Mills JR, Weinshenker BG, Wingerchuk DM, Chen JJ, Tariq Bhatti M, Lopez Chiriboga AS, Pittock SJ, Flanagan EP. Diagnostic value of aquaporin-4-IgG live cell based assay in neuromyelitis optica spectrum disorders. Mult Scler J Exp Transl Clin. 2021 Oct; 7 (4):20552173211052656 Epub 2021 Nov 26
    View PubMed
  115. Zara P, Floris V, Flanagan EP, Lopez-Chiriboga AS, Weinshenker BG, Solla P, Sechi E. Clinical Significance of Myelin Oligodendrocyte Glycoprotein Autoantibodies in Patients with Typical MS Lesions on MRI. Mult Scler J Exp Transl Clin. 2021 Oct; 7 (4):20552173211048761 Epub 2021 Nov 19
    View PubMed
  116. Mustafa R, Passe TJ, Lopez-Chiriboga AS, Weinshenker BG, Krecke KN, Zalewski NL, Diehn FE, Sechi E, Mandrekar J, Kaufmann TJ, Morris PP, Pittock SJ, Toledano M, Lanzino G, Aksamit AJ, Kumar N, Lucchinetti CF, Flanagan EP. Utility of MRI Enhancement Pattern in Myelopathies With Longitudinally Extensive T2 Lesions. Neurol Clin Pract. 2021 Oct; 11 (5):e601-e611
    View PubMed
  117. Sechi E, Flanagan EP. Evaluation and Management of Acute Myelopathy. Semin Neurol. 2021 Oct; 41 (5):511-529 Epub 2021 Oct 07
    View PubMed
  118. Zhao-Fleming HH, Valencia Sanchez C, Sechi E, Inbarasu J, Wijdicks EF, Pittock SJ, Chen JJ, Wingerchuk DM, Weinshenker BG, Lopez-Chiriboga S, Dubey D, Tillema JM, Toledano M, Yadav H, Flanagan EP. CNS Demyelinating Attacks Requiring Ventilatory Support With Myelin Oligodendrocyte Glycoprotein or Aquaporin-4 Antibodies. Neurology. 2021 Sep 28; 97 (13):e1351-e1358 Epub 2021 Aug 13
    View PubMed
  119. Sechi E, Krecke KN, Messina SA, Buciuc M, Pittock SJ, Chen JJ, Weinshenker BG, Lopez-Chiriboga AS, Lucchinetti CF, Zalewski NL, Tillema JM, Kunchok A, Monaco S, Morris PP, Fryer JP, Nguyen A, Greenwood T, Syc-Mazurek SB, Keegan BM, Flanagan EP. Comparison of MRI Lesion Evolution in Different Central Nervous System Demyelinating Disorders. Neurology. 2021 Sep 14; 97 (11):e1097-e1109 Epub 2021 July 14
    View PubMed
  120. Smith KM, Dubey D, Liebo GB, Flanagan EP, Britton JW. Clinical Course and Features of Seizures Associated With LGI1-Antibody Encephalitis. Neurology. 2021 Sep 14; 97 (11):e1141-e1149 Epub 2021 July 07
    View PubMed
  121. Boes CJ, Klaas JP, Tobin WO, Flanagan EP, McKeon A, Braksick SA, Burkholder DB, Stitt DW, Cutsforth-Gregory JK. Harry Lee Parker: Games Lost and Won on the Playing Fields of Neurology. Mayo Clin Proc Innov Qual Outcomes. 2021 Aug; 5 (4):701-719 Epub 2021 July 15
    View PubMed
  122. Jolliffe EA, Guo Y, Hardy TA, Morris PP, Flanagan EP, Lucchinetti CF, Tobin WO. Clinical and Radiologic Features, Pathology, and Treatment of Balo Concentric Sclerosis. Neurology. 2021 Jul 27; 97 (4):e414-e422 Epub 2021 May 19
    View PubMed
  123. Abboud H, Probasco JC, Irani S, Ances B, Benavides DR, Bradshaw M, Christo PP, Dale RC, Fernandez-Fournier M, Flanagan EP, Gadoth A, George P, Grebenciucova E, Jammoul A, Lee ST, Li Y, Matiello M, Morse AM, Rae-Grant A, Rojas G, Rossman I, Schmitt S, Venkatesan A, Vernino S, Pittock SJ, Titulaer MJ, Autoimmune Encephalitis Alliance Clinicians Network. Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management. J Neurol Neurosurg Psychiatry. 2021 Jul; 92 (7):757-768 Epub 2021 Mar 01
    View PubMed
  124. Kunchok A, Flanagan EP, Krecke KN, Chen JJ, Caceres JA, Dominick J, Ferguson I, Kinkel R, Probasco JC, Ruvalcaba M, Santoro JD, Sieloff K, Timothy J, Weinshenker BG, McKeon A, Pittock SJ. MOG-IgG1 and co-existence of neuronal autoantibodies. Mult Scler. 2021 Jul; 27 (8):1175-1186 Epub 2020 Sept 10
    View PubMed
  125. Sechi E, Buciuc M, Pittock SJ, Chen JJ, Fryer JP, Jenkins SM, Budhram A, Weinshenker BG, Lopez-Chiriboga AS, Tillema JM, McKeon A, Mills JR, Tobin WO, Flanagan EP. Positive Predictive Value of Myelin Oligodendrocyte Glycoprotein Autoantibody Testing. JAMA Neurol. 2021 Jun 1; 78 (6):741-746
    View PubMed
  126. Nourbakhsh B, Cordano C, Asteggiano C, Ruprecht K, Otto C, Rutatangwa A, Lui A, Hart J, Flanagan EP, James JA, Waubant E. Multiple Sclerosis Is Rare in Epstein-Barr Virus-Seronegative Children with Central Nervous System Inflammatory Demyelination. Ann Neurol. 2021 Jun; 89 (6):1234-1239 Epub 2021 Mar 24
    View PubMed
  127. Chen JJ, McKeon A, Greenwood TM, Flanagan EP, Bhatti MT, Dubey D, Pulido JS, Iezzi R, Smith WM, Sen HN, Gordon LK, Pittock SJ. Clinical Utility of Antiretinal Antibody Testing. JAMA Ophthalmol. 2021 Jun 1; 139 (6):658-662
    View PubMed
  128. Nayak S, Sechi E, Flanagan EP, Messina S, Kassa R, Kantarci O, Weinshenker BG, Keegan BM. Inflammatory activity following motor progression due to critical CNS demyelinating lesions. Mult Scler. 2021 Jun; 27 (7):1037-1045 Epub 2020 Aug 19
    View PubMed
  129. Kassa RM, Sechi E, Flanagan EP, Kaufmann TJ, Kantarci OH, Weinshenker BG, Mandrekar J, Schmalstieg WF, Paz Soldan MM, Keegan BM. Onset of progressive motor impairment in patients with critical central nervous system demyelinating lesions. Mult Scler. 2021 May; 27 (6):895-902 Epub 2020 July 15
    View PubMed
  130. Valencia-Sanchez C, Flanagan EP. COVID-19 associated with encephalomyeloradiculitis and positive anti-aquaporin-4 antibodies: Cause or coincidence? - Commentary. Mult Scler 2021 May; 27 (6):976-977 Epub 2020 Sept 10
    View PubMed
  131. Shah S, Klassen BT, Flanagan EP. Teaching Video NeuroImages: Paroxysmal Dysarthria-Ataxia in Multiple Sclerosis. Neurology. 2021 Apr 27; 96 (17):e2245-e2246 Epub 2021 Jan 05
    View PubMed
  132. Sechi E, Messina S, Keegan BM, Buciuc M, Pittock SJ, Kantarci OH, Weinshenker BG, Flanagan EP. Critical spinal cord lesions associate with secondary progressive motor impairment in long-standing MS: A population-based case-control study. Mult Scler. 2021 Apr; 27 (5):667-673 Epub 2020 June 18
    View PubMed
  133. Kunchok A, Flanagan EP, Snyder M, Saadeh R, Chen JJ, Weinshenker BG, McKeon A, Pittock SJ. Coexisting systemic and organ-specific autoimmunity in MOG-IgG1-associated disorders versus AQP4-IgG+ NMOSD. Mult Scler. 2021 Apr; 27 (4):630-635 Epub 2020 July 07
    View PubMed
  134. Abboud H, Probasco J, Irani SR, Ances B, Benavides DR, Bradshaw M, Christo PP, Dale RC, Fernandez-Fournier M, Flanagan EP, Gadoth A, George P, Grebenciucova E, Jammoul A, Lee ST, Li Y, Matiello M, Morse AM, Rae-Grant A, Rojas G, Rossman I, Schmitt S, Venkatesan A, Vernino S, Pittock SJ, Titulaer M, Autoimmune Encephalitis Alliance Clinicians Network. Autoimmune encephalitis: proposed recommendations for symptomatic and long-term management. J Neurol Neurosurg Psychiatry. 2021 Mar 1; 92 (8):897-907 Epub 2021 Mar 01
    View PubMed
  135. Budhram A, Sechi E, Flanagan EP, Dubey D, Zekeridou A, Shah SS, Gadoth A, Naddaf E, McKeon A, Pittock SJ, Zalewski NL. Clinical spectrum of high-titre GAD65 antibodies. J Neurol Neurosurg Psychiatry. 2021 Feb 9; 92 (6):645-54 Epub 2021 Feb 09
    View PubMed
  136. Budhram A, Simpson HD, Bower JH, Hassan A, Conway BL, Flanagan EP. Holmes Tremor With Perirolandic Demyelinating Lesions: A Distinct Clinicoradiographic Syndrome. Neurology. 2021 Feb 02; 96(5):231-232. Epub 2020 Nov 20.
    View PubMed
  137. Sechi E, Krecke KN, Pittock SJ, Dubey D, Lopez-Chiriboga AS, Kunchok A, Weinshenker BG, Zalewski NL, Flanagan EP. Frequency and characteristics of MRI-negative myelitis associated with MOG autoantibodies. Mult Scler. 2021 Feb; 27 (2):303-308 Epub 2020 Feb 27
    View PubMed
  138. Lopez Chiriboga S, Flanagan EP. Myelitis and Other Autoimmune Myelopathies. Continuum (Minneap Minn). 2021 Feb 01; 27(1):62-92.
    View PubMed
  139. McKeon A, Shelly S, Zivelonghi C, Basal E, Dubey D, Flanagan E, Madhavan AA, Mariotto S, Toledano M, Tracy JA, Zekeridou A, Pittock SJ. Neuronal intermediate filament IgGs in CSF: Autoimmune Axonopathy Biomarkers. Ann Clin Transl Neurol. 2021 Feb; 8 (2):425-439 Epub 2020 Dec 28
    View PubMed
  140. Shah S, Vazquez Do Campo R, Kumar N, McKeon A, Flanagan EP, Klein C, Pittock SJ, Dubey D. Paraneoplastic Myeloneuropathies: Clinical, Oncologic, and Serologic Accompaniments. Neurology. 2021 Jan 26; 96 (4):e632-e639 Epub 2020 Nov 18
    View PubMed
  141. Webb LM, Chen JJ, Aksamit AJ, Bhattacharyya S, Chwalisz BK, Balaban D, Manzano GS, Ali AS, Lord J, Clardy SL, Samudralwar RD, Mao-Draayer Y, Garrity JA, Bhatti MT, Turner LE, Flanagan EP. A multi-center case series of sarcoid optic neuropathy. J Neurol Sci. 2021 Jan 15; 420:117282 Epub 2020 Dec 19
    View PubMed
  142. Sechi E, Flanagan EP. Antibody-Mediated Autoimmune Diseases of the CNS: Challenges and Approaches to Diagnosis and Management. Front Neurol. 2021; 12:673339 Epub 2021 July 07
    View PubMed
  143. Banks SA, Sechi E, Flanagan EP. Autoimmune encephalopathies presenting as dementia of subacute onset and rapid progression. Ther Adv Neurol Disord. 2021; 14:1756286421998906 Epub 2021 Mar 19
    View PubMed
  144. Valencia-Sanchez C, Pittock SJ, Mead-Harvey C, Dubey D, Flanagan EP, Lopez-Chiriboga S, Trenerry MR, Zalewski NL, Zekeridou A, McKeon A. Brain dysfunction and thyroid antibodies: autoimmune diagnosis and misdiagnosis. Brain Commun. 2021; 3 (2):fcaa233 Epub 2021 Jan 05
    View PubMed
  145. Sechi E, Buciuc M, Flanagan EP, Pittock SJ, Banks SA, Lopez-Chiriboga AS, Bhatti MT, Chen JJ. Variability of cerebrospinal fluid findings by attack phenotype in myelin oligodendrocyte glycoprotein-IgG-associated disorder. Mult Scler Relat Disord 2021 Jan; 47:102638 Epub 2020 Nov 23
    View PubMed
  146. Sechi E, Mariotto S, McKeon A, Krecke KN, Pittock SJ, Ferrari S, Monaco S, Flanagan EP, Zanzoni S, Rabinstein AA, Wingerchuk DM, Nasr DM, Zalewski NL. Serum Neurofilament to Magnetic Resonance Imaging Lesion Area Ratio Differentiates Spinal Cord Infarction From Acute Myelitis. Stroke. 2021 Jan; 52 (2):645-654 Epub 2021 Jan 11
    View PubMed
  147. Banks SA, Morris PP, Chen JJ, Pittock SJ, Sechi E, Kunchok A, Tillema JM, Fryer JP, Weinshenker BG, Krecke KN, Lopez-Chiriboga AS, Nguyen A, Greenwood TM, Lucchinetti CF, Zalewski NL, Messina SA, Flanagan EP. Brainstem and cerebellar involvement in MOG-IgG-associated disorder versus aquaporin-4-IgG and MS. J Neurol Neurosurg Psychiatry. 2020 Dec 28 [Epub ahead of print]
    View PubMed
  148. English SW, Rabinstein AA, Flanagan EP, Zalewski NL. Spinal cord transient ischemic attack: Insights from a series of spontaneous spinal cord infarction. Neurol Clin Pract. 2020 Dec; 10 (6):480-483
    View PubMed
  149. Kunchok A, Chen JJ, Saadeh RS, Wingerchuk DM, Weinshenker BG, Flanagan EP, Pittock SJ. Application of 2015 Seronegative Neuromyelitis Optica Spectrum Disorder Diagnostic Criteria for Patients With Myelin Oligodendrocyte Glycoprotein IgG-Associated Disorders. JAMA Neurol. 2020 Dec 1; 77 (12):1572-1575
    View PubMed
  150. Lopez-Chiriboga AS, Sechi E, Buciuc M, Chen JJ, Pittock SJ, Lucchinetti CF, Flanagan EP. Long-term Outcomes in Patients With Myelin Oligodendrocyte Glycoprotein Immunoglobulin G-Associated Disorder. JAMA Neurol. 2020 Dec 1; 77 (12):1575-1577
    View PubMed
  151. Hassan MB, Stern C, Flanagan EP, Pittock SJ, Kunchok A, Foster RC, Jitprapaikulsan J, Hodge DO, Bhatti MT, Chen JJ. Population-Based Incidence of Optic Neuritis in the Era of Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibodies. Am J Ophthalmol. 2020 Dec; 220:110-114 Epub 2020 July 21
    View PubMed
  152. Madhavan AA, Carr CM, Morris PP, Flanagan EP, Kotsenas AL, Hunt CH, Eckel LJ, Lindell EP, Diehn FE. Imaging Review of Paraneoplastic Neurologic Syndromes. AJNR Am J Neuroradiol. 2020 Dec; 41 (12):2176-2187 Epub 2020 Oct 22
    View PubMed
  153. Budhram A, Dubey D, Sechi E, Flanagan EP, Yang L, Bhayana V, McKeon A, Pittock SJ, Mills JR. Neural Antibody Testing in Patients with Suspected Autoimmune Encephalitis. Clin Chem. 2020 Dec 1; 66 (12):1496-1509
    View PubMed
  154. Buciuc M, Sechi E, Flanagan EP, Lopez-Chiriboga AS. Unfavorable outcome in highly relapsing MOGAD encephalitis. J Neurol Sci 2020 Nov 15; 418:117088 Epub 2020 Aug 10
    View PubMed
  155. Budhram A, Britton JW, Liebo GB, Dubey D, Zekeridou A, Flanagan EP, McKeon A, Pittock SJ, Braksick SA, Zalewski NL. Use of diffusion-weighted imaging to distinguish seizure-related change from limbic encephalitis. J Neurol. 2020 Nov; 267 (11):3337-3342 Epub 2020 June 24
    View PubMed
  156. Dubey D, Wilson MR, Clarkson B, Giannini C, Gandhi M, Cheville J, Lennon VA, Eggers S, Devine MF, Mandel-Brehm C, Kryzer T, Hinson SR, Khazaie K, Hales C, Kattah J, Pavelko KD, Andrews P, Eaton JE, Jitprapaikulsan J, Mills JR, Flanagan EP, Zekeridou A, Leibovich B, Fryer J, Torre M, Kaufman C, Thoreson JB, Sagen J, Linnoila JJ, DeRisi JL, Howe CL, McKeon A, Pittock SJ. Expanded Clinical Phenotype, Oncological Associations, and Immunopathologic Insights of Paraneoplastic Kelch-like Protein-11 Encephalitis. JAMA Neurol. 2020 Nov 1; 77 (11):1420-1429
    View PubMed
  157. Sechi E, Markovic SN, McKeon A, Dubey D, Liewluck T, Lennon VA, Lopez-Chiriboga AS, Klein CJ, Mauermann M, Pittock SJ, Flanagan EP, Zekeridou A. Neurologic autoimmunity and immune checkpoint inhibitors: Autoantibody profiles and outcomes. Neurology. 2020 Oct 27; 95 (17):e2442-e2452 Epub 2020 Aug 13
    View PubMed
  158. Budhram A, Sechi E, Nguyen A, Lopez-Chiriboga AS, Flanagan EP. FLAIR-hyperintense Lesions in Anti-MOG-associated Encephalitis With Seizures (FLAMES): Is immunotherapy always needed to put out the fire? Mult Scler Relat Disord 2020 Sep; 44:102283 Epub 2020 June 11
    View PubMed
  159. Bi H, Hojo K, Watanabe M, Yee C, Maski K, Saba S, Graff-Radford J, Machulda MM, St Louis EK, Humes IS, Flanagan EP, Nicolau S, Jones DT, Patterson MC, Kotagal S, Raz Y, Niu Z, Li J, Klein CJ. Expanded genetic insight and clinical experience of DNMT1-complex disorder. Neurol Genet. 2020 Aug; 6 (4):e456 Epub 2020 June 12
    View PubMed
  160. Chen JJ, Flanagan EP, Bhatti MT, Jitprapaikulsan J, Dubey D, Lopez Chiriboga ASS, Fryer JP, Weinshenker BG, McKeon A, Tillema JM, Lennon VA, Lucchinetti CF, Kunchok A, McClelland CM, Lee MS, Bennett JL, Pelak VS, Van Stavern G, Adesina OO, Eggenberger ER, Acierno MD, Wingerchuk DM, Lam BL, Moss H, Beres S, Gilbert AL, Shah V, Armstrong G, Heidary G, Cestari DM, Stiebel-Kalish H, Pittock SJ. Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorder. Neurology. 2020 Jul 14; 95 (2):e111-e120 Epub 2020 June 17
    View PubMed
  161. Bilodeau PA, Kumar V, Rodriguez AE, Li CT, Sanchez-Alvarez C, Thanarajasingam U, Zalewski NL, Flanagan EP. MOG-IgG myelitis coexisting with systemic lupus erythematosus in the post-partum setting. Mult Scler. 2020 Jul; 26 (8):997-1000 Epub 2019 Oct 17
    View PubMed
  162. Mark IT, Carr CM, Ruff MW, Flanagan EP, Johnson DR. Enlarging Perivascular Spaces Following Radiation Therapy in the Brain: A Report of 2 Cases and Literature Review. World Neurosurg. 2020 Jun; 138:436-439 Epub 2020 Apr 03
    View PubMed
  163. Hoftberger R, Guo Y, Flanagan EP, Lopez-Chiriboga AS, Endmayr V, Hochmeister S, Joldic D, Pittock SJ, Tillema JM, Gorman M, Lassmann H, Lucchinetti CF. The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody. Acta Neuropathol. 2020 May; 139 (5):875-892 Epub 2020 Feb 11
    View PubMed
  164. Budhram A, Kunchok AC, Flanagan EP. Unilateral Leptomeningeal Enhancement in Myelin Oligodendrocyte Glycoprotein Immunoglobulin G-Associated Disease. JAMA Neurol. 2020 May 1; 77 (5):648-649
    View PubMed
  165. Reindl M, Schanda K, Woodhall M, Tea F, Ramanathan S, Sagen J, Fryer JP, Mills J, Teegen B, Mindorf S, Ritter N, Krummrei U, Stocker W, Eggert J, Flanagan EP, Ramberger M, Hegen H, Rostasy K, Berger T, Leite MI, Palace J, Irani SR, Dale RC, Probst C, Probst M, Brilot F, Pittock SJ, Waters P. International multicenter examination of MOG antibody assays. Neurol Neuroimmunol Neuroinflamm. 2020 Mar 5; 7 (2) Epub 2020 Feb 05
    View PubMed
  166. Lopez-Chiriboga AS, Van Stavern G, Flanagan EP, Pittock SJ, Fryer J, Bhatti MT, Chen JJ. Myelin Oligodendrocyte Glycoprotein Antibody (MOG-IgG)-Positive Optic Perineuritis. Neuroophthalmology. 2020 Feb; 44 (1):1-4 Epub 2019 May 28
    View PubMed
  167. Kunchok A, Chen JJ, McKeon A, Mills JR, Flanagan EP, Pittock SJ. Coexistence of Myelin Oligodendrocyte Glycoprotein and Aquaporin-4 Antibodies in Adult and Pediatric Patients. JAMA Neurol. 2020 Feb 1; 77 (2):257-259
    View PubMed
  168. Cohen DA, Bhatti MT, Pulido JS, Lennon VA, Dubey D, Flanagan EP, Pittock SJ, Klein CJ, Chen JJ. Collapsin Response-Mediator Protein 5-Associated Retinitis, Vitritis, and Optic Disc Edema. Ophthalmology. 2020 Feb; 127 (2):221-229 Epub 2019 Sept 20
    View PubMed
  169. Kunchok A, Krecke KN, Flanagan EP, Jitprapaikulsan J, Lopez-Chiriboga AS, Chen JJ, Weinshenker BG, Pittock SJ. Does area postrema syndrome occur in myelin oligodendrocyte glycoprotein-IgG-associated disorders (MOGAD)? Neurology. 2020 Jan 14; 94 (2):85-88 Epub 2019 Dec 11
    View PubMed
  170. Asnafi S, Morris PP, Sechi E, Pittock SJ, Weinshenker BG, Palace J, Messina S, Flanagan EP. The frequency of longitudinally extensive transverse myelitis in MS: A population-based study. Mult Scler Relat Disord. 2020 Jan; 37:101487 Epub 2019 Oct 31
    View PubMed
  171. Chen JJ, Pittock SJ, Flanagan EP, Lennon VA, Bhatti MT. Optic neuritis in the era of biomarkers. Surv Ophthalmol. 2020 Jan - Feb; 65 (1):12-17 Epub 2019 Aug 16
    View PubMed
  172. Turner LE, Pittock SJ, McEvoy MT, Flanagan EP. Overnight loss of pigmented hair in autoimmune autonomic neuropathy treated with IVIg. Neurol Neuroimmunol Neuroinflamm. 2019 Nov; 6 (6) Epub 2019 Sept 25
    View PubMed
  173. Shelly S, Kryzer TJ, Komorowski L, Miske R, Anderson MD, Flanagan EP, Hinson SR, Lennon VA, Pittock SJ, McKeon A. Neurochondrin neurological autoimmunity. Neurol Neuroimmunol Neuroinflamm. 2019 Nov; 6 (6) Epub 2019 Sept 11
    View PubMed
  174. Lopez-Chiriboga S, Pittock SJ, Weinshenker BG, Chen JJ, Flanagan E. Testing for Myelin Oligodendrocyte Glycoprotein Antibody (MOG-IgG) in typical MS. Mult Scler Relat Disord 2019 Oct; 35:34-35 Epub 2019 June 29
    View PubMed
  175. Smith KM, Amin S, Jones LK Jr, Lachance DH, Flanagan EP, Jentoft ME, Kantarci OH. Glial Fibrillary Acidic Protein (GFAP) Autoimmunity in the Setting of Seropositive Rheumatoid Arthritis Treated With Etanercept. Neurologist. 2019 Sep; 24 (5):152-154
    View PubMed
  176. Sechi E, Keegan BM, Kaufmann TJ, Kantarci OH, Weinshenker BG, Flanagan EP. Unilateral motor progression in MS: Association with a critical corticospinal tract lesion. Neurology. 2019 Aug 13; 93 (7):e628-e634 Epub 2019 July 09
    View PubMed
  177. Sechi E, Shosha E, Williams JP, Pittock SJ, Weinshenker BG, Keegan BM, Zalewski NL, Lopez-Chiriboga AS, Jitprapaikulsan J, Flanagan EP. Aquaporin-4 and MOG autoantibody discovery in idiopathic transverse myelitis epidemiology. Neurology. 2019 Jul 23; 93 (4):e414-e420 Epub 2019 June 24
    View PubMed
  178. Flanagan EP. Neuromyelitis Optica Spectrum Disorder and Other Non-Multiple Sclerosis Central Nervous System Inflammatory Diseases. Continuum (Minneap Minn). 2019 Jun; 25 (3):815-844
    View PubMed
  179. Anis S, Regev K, Pittock SJ, Flanagan EP, Alcalay Y, Gadoth A. Isolated recurrent myelitis in a persistent MOG positive patient. Mult Scler Relat Disord. 2019 May; 30:163-164 Epub 2019 Feb 13
    View PubMed
  180. Sechi E, Morris PP, McKeon A, Pittock SJ, Hinson SR, Weinshenker BG, Aksamit AJ, Krecke KN, Kaufmann TJ, Jolliffe EA, Zalewski NL, Zekeridou A, Wingerchuk DM, Jitprapaikulsan J, Flanagan EP. Glial fibrillary acidic protein IgG related myelitis: characterisation and comparison with aquaporin-4-IgG myelitis. J Neurol Neurosurg Psychiatry 2019 Apr; 90 (4):488-490 Epub 2018 July 21
    View PubMed
  181. Waters PJ, Komorowski L, Woodhall M, Lederer S, Majed M, Fryer J, Mills J, Flanagan EP, Irani SR, Kunchok AC, McKeon A, Pittock SJ. A multicenter comparison of MOG-IgG cell-based assays. Neurology. 2019 Mar 12; 92(11):e1250-e1255. Epub 2019 Feb 06.
    View PubMed
  182. Dubey D, Pittock SJ, Krecke KN, Morris PP, Sechi E, Zalewski NL, Weinshenker BG, Shosha E, Lucchinetti CF, Fryer JP, Lopez-Chiriboga AS, Chen JC, Jitprapaikulsan J, McKeon A, Gadoth A, Keegan BM, Tillema JM, Naddaf E, Patterson MC, Messacar K, Tyler KL, Flanagan EP. Clinical, Radiologic, and Prognostic Features of Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Autoantibody. JAMA Neurol. 2019 Mar 1; 76 (3):301-309
    View PubMed
  183. Sechi E, Flanagan EP. Diagnosis and Management of Autoimmune Dementia. Curr Treat Options Neurol. 2019 Feb 27; 21 (3):11
    View PubMed
  184. Sechi E, Parks NE, Koeller KK, Flanagan EP. Hypertrophic olivary degeneration mimics relapse in neuromyelitis optica spectrum disorder. Neurology. 2019 Feb 12; 92 (7):343-344
    View PubMed
  185. Xu SC, Kardon RH, Leavitt JA, Flanagan EP, Pittock SJ, Chen JJ. Optical coherence tomography is highly sensitive in detecting prior optic neuritis. Neurology. 2019 Feb 5; 92 (6):e527-e535 Epub 2019 Jan 23
    View PubMed
  186. Zalewski NL, Rabinstein AA, Krecke KN, Brown RD Jr, Wijdicks EFM, Weinshenker BG, Kaufmann TJ, Morris JM, Aksamit AJ, Bartleson JD, Lanzino G, Blessing MM, Flanagan EP. Characteristics of Spontaneous Spinal Cord Infarction and Proposed Diagnostic Criteria. JAMA Neurol. 2019 Jan 1; 76 (1):56-63
    View PubMed
  187. Zalewski NL, Rabinstein AA, Brinjikji W, Kaufmann TJ, Nasr D, Ruff MW, Flanagan EP. Unique Gadolinium Enhancement Pattern in Spinal Dural Arteriovenous Fistulas. JAMA Neurol. 2018 Dec 1; 75 (12):1542-1545
    View PubMed
  188. Chen JJ, Flanagan EP, Jitprapaikulsan J, Lopez-Chiriboga AS, Fryer JP, Leavitt JA, Weinshenker BG, McKeon A, Tillema JM, Lennon VA, Tobin WO, Keegan BM, Lucchinetti CF, Kantarci OH, McClelland CM, Lee MS, Bennett JL, Pelak VS, Chen Y, VanStavern G, Adesina OO, Eggenberger ER, Acierno MD, Wingerchuk DM, Brazis PW, Sagen J, Pittock SJ. Myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and Outcome. Am J Ophthalmol. 2018 Nov; 195:8-15 Epub 2018 July 26
    View PubMed
  189. López-Chiriboga AS, Majed M, Fryer J, Dubey D, McKeon A, Flanagan EP, Jitprapaikulsan J, Kothapalli N, Tillema JM, Chen J, Weinshenker B, Wingerchuk D, Sagen J, Gadoth A, Lennon VA, Keegan BM, Lucchinetti C, Pittock SJ. Association of MOG-IgG Serostatus With Relapse After Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG-Associated Disorders. JAMA Neurol. 2018 Nov 01; 75(11):1355-1363.
    View PubMed
  190. Cohen DA, Lopez-Chiriboga AS, Pittock SJ, Gadoth A, Zekeridou A, Boilson BA, Hogan WJ, Poterucha JJ, Wilton KM, Lin Y, Flanagan EP. Posttransplant autoimmune encephalitis. Neurol Neuroimmunol Neuroinflamm. 2018 Nov; 5(6):e497. Epub 2018 Aug 20.
    View PubMed
  191. Parks NE, Pittock SJ, Mandrekar J, Kantarci OH, Lucchinetti CF, Weinshenker BG, Keegan BM, Tobin WO, Tillema JM, Toledano M, Flanagan EP. Population-based study of "no evident disease activity" in MS. Neurol Neuroimmunol Neuroinflamm. 2018 Nov; 5 (6):e495 Epub 2018 Aug 16
    View PubMed
  192. Shosha E, Dubey D, Palace J, Nakashima I, Jacob A, Fujihara K, Takahashi T, Whittam D, Leite MI, Misu T, Yoshiki T, Messina S, Elsone L, Majed M, Flanagan E, Gadoth A, Huebert C, Sagen J, Greenberg BM, Levy M, Banerjee A, Weinshenker B, Pittock SJ. Area postrema syndrome: Frequency, criteria, and severity in AQP4-IgG-positive NMOSD. Neurology. 2018 Oct 23; 91 (17):e1642-e1651 Epub 2018 Sept 26
    View PubMed
  193. Dubey D, Kothapalli N, McKeon A, Flanagan EP, Lennon VA, Klein CJ, Britton JW, So E, Boeve BF, Tillema JM, Sadjadi R, Pittock SJ. Predictors of neural-specific autoantibodies and immunotherapy response in patients with cognitive dysfunction. J Neuroimmunol. 2018 Oct 15; 323:62-72 Epub 2018 July 25
    View PubMed
  194. Keegan BM, Kaufmann TJ, Weinshenker BG, Kantarci OH, Schmalstieg WF, Paz Soldan MM, Flanagan EP. Progressive motor impairment from a critically located lesion in highly restricted CNS-demyelinating disease. Mult Scler. 2018 Oct; 24 (11):1445-1452 Epub 2018 July 26
    View PubMed
  195. Jitprapaikulsan J, Chen JJ, Flanagan EP, Tobin WO, Fryer JP, Weinshenker BG, McKeon A, Lennon VA, Leavitt JA, Tillema JM, Lucchinetti C, Keegan BM, Kantarci O, Khanna C, Jenkins SM, Spears GM, Sagan J, Pittock SJ. Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Autoantibody Status Predict Outcome of Recurrent Optic Neuritis. Ophthalmology. 2018 Oct; 125 (10):1628-1637 Epub 2018 Apr 30
    View PubMed
  196. Lopez-Chiriboga AS, Klein C, Zekeridou A, McKeon A, Dubey D, Flanagan EP, Lennon VA, Tillema JM, Wirrell EC, Patterson MC, Gadoth A, Aaen JG, Brenton JN, Bui JD, Moen A, Otten C, Piquet A, Pittock SJ. LGI1 and CASPR2 neurological autoimmunity in children. Ann Neurol. 2018 Sep; 84 (3):473-480
    View PubMed
  197. Chen JJ, Aksamit AJ, McKeon A, Pittock SJ, Weinshenker BG, Leavitt JA, Morris PP, Flanagan EP. Optic Disc Edema in Glial Fibrillary Acidic Protein Autoantibody-Positive Meningoencephalitis. J Neuroophthalmol. 2018 Sep; 38 (3):276-281
    View PubMed
  198. Guerra H, Pittock SJ, Moder KG, Fryer JP, Gadoth A, Flanagan EP. Frequency of Aquaporin-4 Immunoglobulin G in Longitudinally Extensive Transverse Myelitis With Antiphospholipid Antibodies. Mayo Clin Proc. 2018 Sep; 93 (9):1299-1304 Epub 2018 Apr 11
    View PubMed
  199. Zalewski NL, Rabinstein AA, Wijdicks EFM, Petty GW, Pittock SJ, Mantyh WG, Flanagan EP. Spontaneous posterior spinal artery infarction: An under-recognized cause of acute myelopathy. Neurology. 2018 Aug 28; 91 (9):414-417 Epub 2018 July 25
    View PubMed
  200. Dubey D, Hinson SR, Jolliffe EA, Zekeridou A, Flanagan EP, Pittock SJ, Basal E, Drubach DA, Lachance DH, Lennon VA, McKeon A. Autoimmune GFAP astrocytopathy: Prospective evaluation of 90 patients in 1year. J Neuroimmunol. 2018 Aug 15; 321:157-163 Epub 2018 Apr 27
    View PubMed
  201. Jitprapaikulsan J, Lopez Chiriboga AS, Flanagan EP, Fryer JP, McKeon A, Weinshenker BG, Pittock SJ. Novel Glial Targets and Recurrent Longitudinally Extensive Transverse Myelitis. JAMA Neurol. 2018 Jul 1; 75 (7):892-895
    View PubMed
  202. Jolliffe EA, Keegan BM, Flanagan EP. Trident sign trumps Aquaporin-4-IgG ELISA in diagnostic value in a case of longitudinally extensive transverse myelitis. Mult Scler Relat Disord. 2018 Jul; 23:7-8 Epub 2018 Apr 21
    View PubMed
  203. Zalewski NL, Flanagan EP. Autoimmune and Paraneoplastic Myelopathies. Semin Neurol. 2018 Jun; 38 (3):278-289 Epub 2018 July 16
    View PubMed
  204. Lopez-Chiriboga AS, Flanagan EP. Diagnostic and Therapeutic Approach to Autoimmune Neurologic Disorders. Semin Neurol. 2018 Jun; 38 (3):392-402 Epub 2018 July 16
    View PubMed
  205. Mariano R, Flanagan EP, Weinshenker BG, Palace J. A practical approach to the diagnosis of spinal cord lesions. Pract Neurol. 2018 Jun; 18 (3):187-200 Epub 2018 Mar 02
    View PubMed
  206. Zalewski NL, Rabinstein AA, Krecke KN, Brown RD, Wijdicks EFM, Weinshenker BG, Doolittle DA, Flanagan EP. Spinal cord infarction: Clinical and imaging insights from the periprocedural setting. J Neurol Sci. 2018 May 15; 388:162-167 Epub 2018 Mar 17
    View PubMed
  207. English SW, Keegan BM, Flanagan EP, Tobin WO, Zalewski NL. Clinical Reasoning: A 30-year-old man with headache and sleep disturbance. Neurology. 2018 Apr 24; 90 (17):e1535-e1540
    View PubMed
  208. Sharma R, Chakraborty T, Buadi FK, Beam E, Pureza VS, Pagani-Estevez GL, Flanagan EP. Clinical Reasoning: A 56-year-old woman with acute vertigo and diplopia. Neurology. 2018 Apr 17; 90 (16):748-752
    View PubMed
  209. Chen JJ, Tobin WO, Majed M, Jitprapaikulsan J, Fryer JP, Leavitt JA, Flanagan EP, McKeon A, Pittock SJ. Prevalence of Myelin Oligodendrocyte Glycoprotein and Aquaporin-4-IgG in Patients in the Optic Neuritis Treatment Trial. JAMA Ophthalmol. 2018 Apr 1; 136 (4):419-422
    View PubMed
  210. Murphy BL, Zalewski NL, Degnim AC, McKeon A, Flanagan EP, Pittock SJ, Habermann EB. Breast cancer-related paraneoplastic neurologic disease. Breast Cancer Res Treat. 2018 Feb; 167 (3):771-778 Epub 2017 Nov 07
    View PubMed
  211. Dubey D, Lennon VA, Gadoth A, Pittock SJ, Flanagan EP, Schmeling JE, McKeon A, Klein CJ. Autoimmune CRMP5 neuropathy phenotype and outcome defined from 105 cases. Neurology. 2018 Jan 9; 90 (2):e103-e110 Epub 2017 Dec 08
    View PubMed
  212. Zalewski NL, Flanagan EP, Keegan BM. Evaluation of idiopathic transverse myelitis revealing specific myelopathy diagnoses. Neurology. 2018 Jan 9; 90 (2):e96-e102 Epub 2017 Dec 15
    View PubMed
  213. Stitt DW, Boes CJ, Flanagan EP, Howard MT, Colgan JP. A Case of cutaneous large B-cell lymphoma during treatment of multiple sclerosis with fingolimod. Mult Scler Relat Disord. 2018 Jan; 19:115-117 Epub 2017 Nov 16
    View PubMed
  214. Dubey D, Pittock SJ, Kelly CR, McKeon A, Lopez-Chiriboga AS, Lennon VA, Gadoth A, Smith CY, Bryant SC, Klein CJ, Aksamit AJ, Toledano M, Boeve BF, Tillema JM, Flanagan EP. Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis. Ann Neurol. 2018 Jan; 83 (1):166-177
    View PubMed
  215. Parks NE, Flanagan EP, Lucchinetti CF, Wingerchuk DM. NEDA treatment target? No evident disease activity as an actionable outcome in practice. J Neurol Sci. 2017 Dec 15; 383:31-34 Epub 2017 Oct 13
    View PubMed
  216. Shosha E, Pittock SJ, Flanagan E, Weinshenker BG. Neuromyelitis optica spectrum disorders and pregnancy: Interactions and management. Mult Scler. 2017 Dec; 23 (14):1808-1817
    View PubMed
  217. Dubey D, Forsthuber T, Flanagan EP, Pittock SJ, Stuve O. B-cell-targeted therapies in relapsing forms of MS. Neurol Neuroimmunol Neuroinflamm. 2017 Nov; 4 (6):e405 Epub 2017 Oct 23
    View PubMed
  218. Ali F, Murray JA, Adams AC, Flanagan EP. Clinical Reasoning: A 54-year-old woman with dementia, myoclonus, and ataxia. Neurology. 2017 Jul 11; 89 (2):e7-e12
    View PubMed
  219. Gadoth A, Pittock SJ, Dubey D, McKeon A, Britton JW, Schmeling JE, Smith A, Kotsenas AL, Watson RE, Lachance DH, Flanagan EP, Lennon VA, Klein CJ. Expanded phenotypes and outcomes among 256 LGI1/CASPR2-IgG-positive patients. Ann Neurol. 2017 Jul; 82 (1):79-92
    View PubMed
  220. Gadoth A, Singh J, Britton JW, Flanagan EP, Pittock SJ. Dacrystic seizures-a cry for help. Neurol Neuroimmunol Neuroinflamm. 2017 Jul; 4 (4):e372 Epub 2017 June 16
    View PubMed
  221. Savoldi F, Kaufmann TJ, Flanagan EP, Toledano M, Weinshenker BG. Elsberg syndrome: A rarely recognized cause of cauda equina syndrome and lower thoracic myelitis. Neurol Neuroimmunol Neuroinflamm. 2017 Jul; 4 (4):e355 Epub 2017 May 11
    View PubMed
  222. Dubey D, Singh J, Britton JW, Pittock SJ, Flanagan EP, Lennon VA, Tillema JM, Wirrell E, Shin C, So E, Cascino GD, Wingerchuk DM, Hoerth MT, Shih JJ, Nickels KC, McKeon A. Predictive models in the diagnosis and treatment of autoimmune epilepsy. Epilepsia. 2017 Jul; 58 (7):1181-1189 Epub 2017 May 26
    View PubMed
  223. Asgari N, Flanagan EP, Fujihara K, Kim HJ, Skejoe HP, Wuerfel J, Kuroda H, Kim SH, Maillart E, Marignier R, Pittock SJ, Paul F, Weinshenker BG. Disruption of the leptomeningeal blood barrier in neuromyelitis optica spectrum disorder. Neurol Neuroimmunol Neuroinflamm. 2017 Jul; 4 (4):e343 Epub 2017 Apr 21
    View PubMed
  224. Lopez Chiriboga AS, Siegel JL, Tatum WO, Shih JJ, Flanagan EP. Striking basal ganglia imaging abnormalities in LGI1 ab faciobrachial dystonic seizures. Neurol Neuroimmunol Neuroinflamm. 2017 May; 4 (3):e336 Epub 2017 Mar 14
    View PubMed
  225. Dubey D, Pittock SJ, Krecke KN, Flanagan EP. Association of Extension of Cervical Cord Lesion and Area Postrema Syndrome With Neuromyelitis Optica Spectrum Disorder. JAMA Neurol. 2017 Mar 1; 74 (3):359-361
    View PubMed
  226. Zalewski NL, Morris PP, Weinshenker BG, Lucchinetti CF, Guo Y, Pittock SJ, Krecke KN, Kaufmann TJ, Wingerchuk DM, Kumar N, Flanagan EP. Ring-enhancing spinal cord lesions in neuromyelitis optica spectrum disorders. J Neurol Neurosurg Psychiatry. 2017 Mar; 88 (3):218-225 Epub 2016 Dec 02
    View PubMed
  227. Flanagan EP, Hinson SR, Lennon VA, Fang B, Aksamit AJ, Morris PP, Basal E, Honorat JA, Alfugham NB, Linnoila JJ, Weinshenker BG, Pittock SJ, McKeon A. Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: Analysis of 102 patients. Ann Neurol. 2017 Feb; 81 (2):298-309
    View PubMed
  228. Lopez-Chiriboga AS, Huang JF, Flanagan EP, Cheshire WP Jr. Paroxysmal sneezing in NMOSD: Further evidence of the localization of the human sneeze center. Neurol Neuroimmunol Neuroinflamm. 2017 Jan; 4 (1):e303 Epub 2016 Oct 28
    View PubMed
  229. Flanagan EP, Pittock SJ. Diagnosis and management of spinal cord emergencies. Handb Clin Neurol. 2017; 140:319-335
    View PubMed
  230. Conway BL, Clarke MJ, Kaufmann TJ, Flanagan EP. Utility of extension views in spondylotic myelopathy mimicking transverse myelitis. Mult Scler Relat Disord. 2017 Jan; 11:62-64.
    View PubMed
  231. Keegan BM, Kaufmann TJ, Weinshenker BG, Kantarci OH, Schmalstieg WF, Paz Soldan MM, Flanagan EP. Progressive solitary sclerosis: Gradual motor impairment from a single CNS demyelinating lesion. Neurology. 2016 Oct 18; 87 (16):1713-1719 Epub 2016 Sept 16
    View PubMed
  232. Zalewski NL, Krecke KN, Weinshenker BG, Aksamit AJ, Conway BL, McKeon A, Flanagan EP. Central canal enhancement and the trident sign in spinal cord sarcoidosis. Neurology. 2016 Aug 16; 87 (7):743-4
    View PubMed
  233. Flanagan EP, Cabre P, Weinshenker BG, Sauver JS, St Sauver J, Jacobson DJ, Majed M, Lennon VA, Lucchinetti CF, McKeon A, Matiello M, Kale N, Wingerchuk DM, Mandrekar J, Sagen JA, Fryer JP, Robinson AB, Pittock SJ. Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum. Ann Neurol. 2016 May; 79 (5):775-783 Epub 2016 Apr 04
    View PubMed
  234. Flanagan EP, Kaufmann TJ, Krecke KN, Aksamit AJ, Pittock SJ, Keegan BM, Giannini C, Weinshenker BG. Discriminating long myelitis of neuromyelitis optica from sarcoidosis. Ann Neurol. 2016 Mar; 79 (3):437-47 Epub 2016 Feb 12
    View PubMed
  235. Flanagan EP, Duffy JR, Whitwell JL, Vemuri P, Dickson DW, Josephs KA. Mixed tau and TDP-43 pathology in a patient with unclassifiable primary progressive aphasia. Neurocase. 2016; 22 (1):55-9 Epub 2015 May 01
    View PubMed
  236. Flanagan EP. Autoimmune myelopathies. Handb Clin Neurol. 2016; 133:327-51
    View PubMed
  237. Flanagan EP, Drubach DA, Boeve BF. Autoimmune dementia and encephalopathy. Handb Clin Neurol. 2016; 133:247-67
    View PubMed
  238. McCarter SJ, Tippmann-Peikert M, Sandness DJ, Flanagan EP, Kantarci K, Boeve BF, Silber MH, St Louis EK. Neuroimaging-evident lesional pathology associated with REM sleep behavior disorder. Sleep Med. 2015 Dec; 16: (12)1502-10.
    View PubMed
  239. Flanagan EP, Kotsenas AL, Britton JW, McKeon A, Watson RE, Klein CJ, Boeve BF, Lowe V, Ahlskog JE, Shin C, Boes CJ, Crum BA, Laughlin RS, Pittock SJ. Basal ganglia T1 hyperintensity in LGI1-autoantibody faciobrachial dystonic seizures. Neurol Neuroimmunol Neuroinflamm. 2015 Dec; 2 (6):e161 Epub 2015 Oct 01
    View PubMed
  240. Jones AL, Flanagan EP, Pittock SJ, Mandrekar JN, Eggers SD, Ahlskog JE, McKeon A. Responses to and Outcomes of Treatment of Autoimmune Cerebellar Ataxia in Adults. JAMA Neurol. 2015 Nov; 72 (11):1304-12
    View PubMed
  241. Pichler MR, Flanagan EP, Aksamit AJ, Leavitt JA, Salomao DR, Keegan BM. Conjunctival biopsy to diagnose neurosarcoidosis in patients with inflammatory nervous system disease of unknown etiology. Neurol Clin Pract. 2015 Jun; 5 (3):216-223
    View PubMed
  242. Flanagan EP, Weinshenker BG, Krecke KN, Pittock SJ. Asymptomatic myelitis in neuromyelitis optica and autoimmune aquaporin-4 channelopathy. Neurol Clin Pract. 2015 Apr; 5 (2):175-177
    View PubMed
  243. Flanagan EP, Baker MC, Perkerson RB, Duffy JR, Strand EA, Whitwell JL, Machulda MM, Rademakers R, Josephs KA. Dominant frontotemporal dementia mutations in 140 cases of primary progressive aphasia and speech apraxia. Dement Geriatr Cogn Disord. 2015; 39 (5-6):281-6 Epub 2015 Feb 28
    View PubMed
  244. Flanagan EP, Weinshenker BG, Krecke KN, Lennon VA, Lucchinetti CF, McKeon A, Wingerchuk DM, Shuster EA, Jiao Y, Horta ES, Pittock SJ. Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders. JAMA Neurol. 2015 Jan; 72 (1):81-7
    View PubMed
  245. Flanagan EP, Saito YA, Lennon VA, McKeon A, Fealey RD, Szarka LA, Murray JA, Foxx-Orenstein AE, Fox JC, Pittock SJ. Immunotherapy trial as diagnostic test in evaluating patients with presumed autoimmune gastrointestinal dysmotility. Neurogastroenterol Motil. 2014 Sep; 26 (9):1285-97 Epub 2014 July 20
    View PubMed
  246. Flanagan EP, Weinshenker BG. Neuromyelitis optica spectrum disorders. Curr Neurol Neurosci Rep. 2014 Sep; 14 (9):483
    View PubMed
  247. Flanagan EP, Krecke KN, Marsh RW, Giannini C, Keegan BM, Weinshenker BG. Specific pattern of gadolinium enhancement in spondylotic myelopathy. Ann Neurol. 2014 Jul; 76: (1)54-65.
    View PubMed
  248. Flanagan EP, Leep Hunderfund AN, Kumar N, Murray JA, Krecke KN, Katz BS, Pittock SJ. Clinical reasoning: a 55-year-old man with weight loss, ataxia, and foot drop. Neurology. 2014 Jun 17; 82 (24):e214-9
    View PubMed
  249. Flanagan EP, Knopman DS, Keegan BM. Dementia in MS complicated by coexistent Alzheimer disease: Diagnosis premortem and postmortem. Neurol Clin Pract. 2014 Jun; 4 (3):226-230
    View PubMed
  250. Flanagan EP, McKeon A, Weinshenker BG. Anterior spinal artery infarction causing man-in-the-barrel syndrome. Neurol Clin Pract. 2014 Jun; 4 (3):268-269
    View PubMed
  251. Groarke PJ, Kelly JC, Flanagan E, et al. The forgotten foot - An assessment of foot and ankle radiograph pathology in final year medical students. Surgeon. 2014 Apr 27.
  252. Flanagan EP, Rabinstein AA, Kumar N, Schroeder K, Kantarci OH. Fulminant cerebellitis with radiological recurrence in an adult patient with Crohn's disease. J Neurol Sci. 2014 Jan 15; 336: (1-2)247-50.
    View PubMed
  253. Child ND, Braksick SA, Flanagan EP, Keegan BM, Giannini C, Kantarci OH. Amyloid-beta-related angiitis presenting as a uveomeningeal syndrome. Neurology. 2013 Nov 12; 81: (20)1796-8.
    View PubMed
  254. Taylor JW, Flanagan EP, O'Neill BP, Siegal T, Omuro A, Deangelis L, Baehring J, Nishikawa R, Pinto F, Chamberlain M, Hoang-Xuan K, Gonzalez-Aguilar A, Batchelor T, Blay JY, Korfel A, Betensky RA, Lopes MB, Schiff D. Primary leptomeningeal lymphoma: International Primary CNS Lymphoma Collaborative Group report. Neurology. 2013 Nov 5; 81 (19):1690-6 Epub 2013 Oct 09
    View PubMed
  255. Flanagan EP, Hunt CH, Lowe V, Mandrekar J, Pittock SJ, O'Neill BP, Keegan BM. [(18)F]-fluorodeoxyglucose-positron emission tomography in patients with active myelopathy. Mayo Clin Proc. 2013 Nov; 88 (11):1204-12
    View PubMed
  256. Flanagan EP, Aksamit AJ, Kumar N, Morparia NP, Keegan BM, Weinshenker BG. Simultaneous PML-IRIS and myelitis in a patient with neuromyelitis optica spectrum disorder. Neurol Clin Pract. 2013 Oct; 3 (5):448-451
    View PubMed
  257. Flanagan EP, Kaufmann TJ, Keegan BM. Sjogren's syndrome with trigeminal neuropathy: motor involvement. Pract Neurol. 2013 Oct; 13(5):340-2. Epub 2013 May 23.
    View PubMed
  258. Flanagan EP, Marsh RW, Weinshenker BG. Teaching neuroimages: "pancake-like" gadolinium enhancement suggests compressive myelopathy due to spondylosis. Neurology. 2013 May 21; 80(21):e229.
    View PubMed
  259. Flanagan EP, Keegan BM. Paraneoplastic myelopathy. Neurol Clin. 2013 Feb; 31 (1):307-18
    View PubMed
  260. Flanagan EP, Gavrilova RH, Boeve BF, Kumar N, Jelsing EJ, Silber MH. Adult-onset autosomal dominant leukodystrophy presenting with REM sleep behavior disorder. Neurology. 2013 Jan 1; 80(1):118-20. Epub 2012 Dec 12.
    View PubMed
  261. Flanagan EP, Sandroni P, Pittock SJ, Inwards DJ, Jones LK Jr. Paraneoplastic lower motor neuronopathy associated with Hodgkin lymphoma. Muscle Nerve. 2012 Nov; 46(5):823-7.
    View PubMed
  262. Groarke P, Kelly J, Flanagan E, et al. A pain in the neck--medical student attitudes to the Orthopaedic spine. Ir Med J. 2012 Sep; 105(8):274-5.
  263. Flanagan EP, O'Neill BP, Habermann TM, Porter AB, Keegan BM. Secondary intramedullary spinal cord non-Hodgkin's lymphoma. J Neurooncol. 2012 May; 107 (3):575-80 Epub 2011 Dec 22
    View PubMed
  264. Flanagan EP, Hunderfund AL, Giannini C, Meissner I. Addition of magnetic resonance imaging to computed tomography and sensitivity to blood in pituitary apoplexy. Arch Neurol. 2011 Oct; 68: (10)1336-7.
    View PubMed
  265. Flanagan EP, O'Neill BP, Porter AB, Lanzino G, Haberman TM, Keegan BM. Primary intramedullary spinal cord lymphoma. Neurology. 2011 Aug 23; 77 (8):784-91 Epub 2011 Aug 10
    View PubMed
  266. Flanagan EP, Lennon VA, Pittock SJ. Autoimmune myelopathies. Continuum.2011 Aug;17:(4):776-99.
  267. Flanagan EP, McKeon A, Lennon VA, Kearns J, Weinshenker BG, Krecke KN, Matiello M, Keegan BM, Mokri B, Aksamit AJ, Pittock SJ. Paraneoplastic isolated myelopathy: clinical course and neuroimaging clues. Neurology. 2011 Jun 14; 76(24):2089-95.
    View PubMed
  268. Flanagan EP, Caselli RJ. Autoimmune encephalopathy. Semin Neurol. 2011 Apr; 31 (2):144-57 Epub 2011 May 17
    View PubMed
  269. Kelly JC, Groarke PJ, Flanagan E, et al. Foot and ankle surgery - The Achilles heel of medical students and doctors. The Foot 8. 2010 Dec.
  270. Flanagan EP, McKeon A, Lennon VA, Boeve BF, Trenerry MR, Tan KM, Drubach DA, Josephs KA, Britton JW, Mandrekar JN, Lowe V, Parisi JE, Pittock SJ. Autoimmune dementia: clinical course and predictors of immunotherapy response. Mayo Clin Proc. 2010 Oct; 85 (10):881-97
    View PubMed
  271. Zinchuk AV, Flanagan EP, Tubridy NJ, et al. Attitudes of US medical trainees towards neurology education: "Neurophobia" - a global issue. BMC Medical Education Jun 23;. 2010; 10:49.
  272. Flanagan E, Walsh C, Tubridy N. 'Neurophobia' - Attitudes of medical students and doctors in Ireland to neurological teaching. The European Journal of Neurology.2007;14:1109-12.
PST-20216465